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ABSTRACT
Incidence and Clinical Predictors o f Risk Factors for Inappropriate Shock in Patients with
Implantable Cardioverter-Defibrillators
Shu-Ling Lo
Sudden cardiac death (SCD) is a major unresolved medical problem worldwide.
Although Implantable Cardioverter-Defibrillators(ICD) are highly effective in diagnosing
and treating life threatening arrhythmias, inappropriate shock therapy (1ST) occurs in
approximately 5-20% o f ICD recipients. 1ST results in pain, anxiety, induction of
ventricular arrhythmias, decreased battery longevity, and even death. Researchers
studying clinical predictors o f 1ST have drawn findings based on single case studies with
small samples or with out-dated data. This study filled this gap by describing the
incidence and co-existing clinical predictors o f 1ST.
Methodology
This descriptive, retrospective study analyzed the incidence and clinical predictors o f 1ST
in ICD adult recipients by utilizing a five-year retrospective review ICD interrogation
records and medical charts at a university hospital.
Results
During a mean follow-up period o f 24.1 ± 16.2 months, 20 out o f 119 ICD recipients
received appropriate shock, and 1ST occurred in 13(9%) out o f 119 ICD recipients. A
total o f 16 1ST experiences occurred among these 13 patients. Eight subjects received 1ST
for atrial fibrillation (AF)/atria tachycardia or sinus tachycardia/normal sinus rhythm, two
for double counting, two for lead problems, and one for drug interaction. O f these, 12 out
o f 98 men received 1ST. One out o f 21 women received 1ST. Using Chi-square and
logistic regression analysis, results showed only AF as a significant predictor (p=.002 vs
0.001) and remains the main cause o f 1ST. Although the variables o f age, gender, NYHA
class LVEF and structural heart disease showed no significant relationship. Trigger
events occurred during clinical interventions and were noted in this study.
Conclusion
The clinical characteristics o f patients prone to 1ST should be carefully considered when
planning clinical interventions. With the rapid expansion o f this patient population, a
multisite expanded longitudinal study is indicated to confirm the results seen in this
initial descriptive study.
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CHAPTER I
STUDY PROBLEM AND ITS SIGNIFICANCE
Background
Sudden cardiac death (SCD) is defined as death from abrupt, unexpected circulatory
arrest occurring w ithin a short period, generally less than an hour, following the onset o f
acute symptoms (Jeanne, Poole & Bardy, 2004). SCD occurs in about 450,000 people in
the United States each year (American H eart Association, 2005). It also affects a
significant num ber o f people in many other countries (Connolly, Gent, Roberts, 2000;
Spector, 2005). SCD is a major unresolved public health problem in the U.S. and
throughout the world. It is often attributed to untreated, life threatening, ventricular
arrhythmia (Bardy, 2004). Attempts to prevent SCD with antiarrhythm ic agents have m et
with little success and may even increase m ortality (Cardiac A rrhythm ia Suppression
Trial II Investigators, 1992). Some nontypical antiarrhythm ic agents (e.g., 13 blockers),
have dem onstrated a reduction in arrhythmic deaths by reducing the ischem ic burden.
Revascularization is most often used as the first line o f intervention for the reduction o f
sudden death risk in ischemic patients (Spector, 2005). However, the limited efficacy o f
SCD prevention and the failure o f resuscitation from out-of-hospital cardiac arrest
renders SCD a significant problem. The developm ent o f the im plantable cardioverter
defibrillator (ICD), which almost instantly detects and treats life - threatening ventricular
arrhythm ia has in recent years revolutionized the treatm ent o f SCD (M irowki, Reid,
M ower, Watkins, & Gott, 1980).

1
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1ST in patients with ICDs 2
The advent o f the ICDs has resulted in a significant decrease in the rate o f SCD
from ventricular tachycardia (VT) and ventricular fibrillation (VF) in specific populations
(Moss, Hall, Cannom, Daubert, Higgins, Kiel, et al., 1996). With the advent o f
monitoring capabilities from the ICD, there has been a tremendous change in the
prevention o f sudden arrhythmia death (Moss, Zareba, & Hall, 2002; Naccareli, 2004).
The ICD is responsible for sending electrical signals that satisfy programmed criteria and
is highly effective in reverting such rhythms back to normal (Klein, Auricchio, Reck, &
Geller, 1999). An appropriate shock was defined as a spontaneous ICD discharge that
terminated with such clinical symptoms as palpitations, nausea, dizziness, light
headedness, or syncope (Schreieck, Zrenne, Kolb, Ndrepepa, & Schmitt, 2001). The ICD
functions by delivering shocks in response to electrical signals that satisfy
preprogrammed criteria, and it is highly effective in reverting VT and VF to normal
rhythms (Klein, Auricchio, Reck, & Geller, 1999). Clinical trials have demonstrated that
the ICD is superior to medication in prolonging the lives o f individuals with a history o f
prior or inducible, sustained, ventricular arrhythmia (i.e., VT longer than 30 seconds;
Antiarrhythmics Versus Implantable Defibrillators [AVID], 1997; Kuck, Cappato, Siebels,
& Ruppel, 2000). With the completion o f multiple randomized clinical trails, ICDs have
emerged as the dominant therapy for the secondary and primary prevention o f SCD
(Bardy et al., 2005, Connolly et al., 2000; Kuck et al.; Moss et al., 2002; Sheldon,
Connolly, Krahn, 2000). In addition to the secondary and primary prevention o f SCD,
ICDs have an emerging indication for dilated cardiomyopathy (DCM) (Bansch, Antz,
Boczor, Volkmer, Tebbenjohanns, Karlheinz et al., 2002). The current "Practice
Guidelines o f Indications fo r Implantable Cardioverter - Defibrillator Therapy”
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1ST in patients with ICDs 3
(Gregoratos, Abrams, Epstein, Freedam, David, & Hayes et al., 2002) is based on the
clinical trails (Appendix A) developed by the expert panel o f ACC/AHA/NASPE in 2002
(Appendix B). Along with the therapies for the secondary and prim ary prevention o f
SCD, the ICD indications expanded to chronic heart failure and DCM (Abraham, 2003;
Guidant Atrial Features Guide, 2001). A substantial increase in the implantation of ICDs
is expected because o f these expanded indications.

Statement o f the Problem
ICDs are accurate and effective in the diagnosis and treatment o f VT and VE
However, inappropriate shock therapy (1ST), defined as shocks occurring in the absence
of life threatening ventricular arrhythmias, occurs in approximately 5% - 20% o f ICD
patients (Grimm, Flores, & Marchlinski, 1993; Lauria, Glikson, Brady, Lexvold,
Rasmussen, Hodge, et al., 2001, Rosenqvist, Beyer, Block, Den Dulk, Minten, &
Lindemans, 1998; Theuns, Klootwijk, Simoons, & Jordaens, 2005). Inappropriate therapy
shocks are hazardous because the consequences o f 1ST are severe and have been reported
in many studies (Messali, Thomas, Chauvin, Conmel and Leenhardt, 2004; Steinbrook,
2005).
Impacts o f Inappropriate Shock
Physiological Im pact
Patients have described the sensation o f an inappropriate shock as a pain similar
to being punched in the chest or kicked by a horse (Thomas, 2001). 1ST, apart from
being painful, m ay also cause myocardial damage, as documented in animal and human
studies (Epstein, Kay, Plumb, Dailey, Peter, & Anderson, 1998). Due to 1ST,
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proarrhythmia is also a frequently reported event (Pinski & Fahy, 1995). Pinski and Fahy
reported on death from 1ST, and Messali, Thomas, Chauvin, Coumel, and Leenhardt
(2004) also recorded deaths in their research, with the rate varying from 0.4% to 8%. The
risk for proarrhythmia appeared to be most common in situations with fast
superventricular rhythms with a concomitant increase in sympathetic discharge, raterelated disease in ventricular refractoriness, or myocardial ischemia (Pinski & Fahy,
1995).
Psychological Impact
Although the ICD is a lifesaving device, living w ith the possibility o f receiving a
defibrillating shock at any time can be emotionally devastating. One small study
(Dougherty, 1995) and a national survey (Sears & Conti, 2002) found that patients
receiving ICD shocks, along with their families, experienced more anxiety, anger,
depression, and stress than patients and families who had not received shocks. A study o f
57 patients (Luderitz, Jung, Diester, M ameros, & Manz, 1993) found that patients who
had experienced five or more shocks from an ICD had a higher state o f anxiety than those
who experienced fewer than five shocks. In another study o f the impact o f ICD therapy
(Godemann, Butter, Lampe, Linden, Schlegl, Schulth, et al., 2004), the results
demonstrated that, in patients who have two or more ICD discharges annually, the
incidence o f panic disorders and agoraphobia were higher than in those who only
received a single ICD discharge annually. Patients’ level o f psychological symptoms was
correlated with fear o f ICD malfunction, particularly anxiety, depression, and fear o f
death (Dougherty, 2004). The manner o f how one’s quality o f life was affected by ICD
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shock(s) has been reported in several studies (Sears, Eads, Marhefka, 2002; Carroll &
Hamilton, 2005).
Economic Impact
Other m ajor negative impacts o f 1ST include the induction o f ventricular
arrhythmias and a decrease in life longevity o f battery caused by frequent shocks (Lin,
Dixit, Russia, & Hsia, 2004). As the results o f these effects, the replacement o f already
expensive ICDs will require additional costs. In addition, the fees o f diagnostic
procedures, treatments, and frequent clinical visits’ fees must be paid as well. The
unfavorable cost effectiveness resulting from ISTs ultimately m ay become a financial
burden for the health care system.
Predisposing Clinical Characteristically Factors Are Not Well Known
Many inappropriate ICD discharges are caused by supraventricular arrhythmias
that are triggered by a problem with the ICD device, or that occur at a time when the
environment interferes with the ICD (Pinski & Trohman, 2002; Rinaddi, Simmon,
Bostock, Elliot, & Gill, 2004). However, patients and clinicians report that inappropriate
shocks still occur with no identifiable causes (Champagne, Geelen, Philippon, & Brugada,
2005; Glikson, 2004). The literature review dem onstrated that, in the majority o f patients
who are at risk for an 1ST, the clinical predictors o f ISTs are not well known. In addition,
neither the timing nor the circumstances under which an 1ST occurred (e.g., exercise,
dehydration) were correlated to occurrence o f inappropriate therapy (Healy, Ngarmukos,
& Rosenthal, 2002). Many case studies, consisting o f only one to four patients, provided
in-depth information about the incidence o f inappropriate shock (Healy, 2002; Messali,
2004; Peters, 1998). However, these findings cannot be generalized due to limited data

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1ST in patients with ICDs 6
(Bums & Grove, 2004). As a result, there exists no exhaustive list o f what may or may
not affect an ICD. The multitude o f variables makes it impossible to know how a device
will respond to various sources o f interference. Misinformation and outdated information
perpetuated within the medical community cloud these issues.
Current Status o f Intervention Programs
Many respected nursing researchers have explored the impact o f ICD therapy,
including interventions to promote the quality o f life for ICD recipients and their families
(Carlesson, Olesson & Hertervig, 2002; Shea, 2004; Sneed, 1997; Vitale & Funk, 1995).
Educational intervention programming related to psychological aspects has also been
discussed extensively (Dougherty et al., 2004; Higgins, 1990; Sneed, Fench, & Michel,
1997; White, 2002). However, care practices are likely to have evolved that do not
encompass the physiological elements. Few studies have provided information regarding
the experience o f shock itself or have made distinctions between appropriate shock and
inappropriate shock. Recently, an educational program developed by Dougherty et al.
made suggestions for the educational intervention o f ICD recipients. Their suggestions
were based solely on the number o f shock events and the level o f pain experienced,
which might not accurately reflect the seriousness o f a shock event. For example, a
patient could feel pain when he/she experienced a “phantom shock” in which no true
shock occurred but the patient claimed to feel pain). Conversely, a patient might not feel
pain due to his/her loss o f conscious from a high-energy shock. In a recent nursing care
journal discussing the issues o f patients with ICDs, Dunbar (2005) intended to discuss all
areas o f concerns from psychosocial aspect. However, it was not clear whether the
author intended to give information to prevent an inappropriate shock or address
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appropriate shock in the nursing care o f patients with ICDs. The author stated that,
“Known predictors o f inappropriate shock are history o f atrial tachyarrhythmia and
recurrent ventricular tachycardia that have triggered appropriate therapy”(p.297).
Moreover, there are still many other risk factors that could trigger inappropriate shocks
and appropriate shocks. Hence, without sufficient published information, it would be
difficult to provide effective educational programs. O ’Brien, Langberg, Valderrma,
Kirkendoll, Romeiko and Dunbar (2005) investigated patients and families involving
ICD storms, where patients experience two or more appropriate and/or inappropriate
shocks within 24 hours. This study provided great insight into the effects o f an ICD storm
and the management o f shocks; however, intervention for preventing the occurrence o f an
inappropriate shock event remains an unsolved problem. Appendix C summarizes the last
five years o f nursing research related to care o f the ICD recipients.
Future Technological Considerations
As ICDs become more complicated, the incidence o f inappropriate shock is likely
to increase (Rinaddi, Simmon, Bostock, Elliot, Bcknall, & Gill, 2004). In addition, there
has been a corresponding increase in the number and complexity o f patients seen in
follow-up visits after ICD implantation. This increased visitation volume demands that
clinical practice create alternative methods to safely and effectively monitor these
patients. Recently, the internet-based remote monitoring service has allowed clinicians to
remotely manage their patients' ICDs and chronic diseases. The network is comprised of
a patient monitor, a secured server, and clinician and patient websites. Under clinical
direction, patients interrogate their ICDs at home and transmit data to a secure server via
standard telephone lines (Joseph, Wilkoff, Dresing, Burkhardt, & Khaykin, 2004).
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Patients have become critical consumers o f health care and are frequently using the
internet as a resource for their health concerns and treatment options. Cardiovascular
nurses have a unique opportunity to assist patients using this modality. Web pages
provide interactive patient education, including behavioral interventions, for risk
reduction management in ICD therapy. This study serves as an exemplar for how
cardiovascular nurses can work with these valuable tools for patient care.

The Role o f Cardiovascular Nurses in the Management o f Inappropriate Shock Therapy
from a Physiological Aspect
The nursing profession plays an important role in the delivery o f health services,
particularly for cardiovascular patients. Nurses are responsible for recognizing “cue
complexes,” or syndromes, and for providing prompt emergency treatment (e.g., cardiac
resuscitation). Nurses also provide appropriate information to the ICD recipients and
their families regarding the diagnosis or plan o f therapy following physician-nurse
appraisal (Roger, 1971). One goal o f advanced cardiovascular nurses is to integrate
technology with patents’ everyday lives. Cardiovascular nurses can play a pivotal role in
providing optimal care for ICD patients. Through effective nursing interventions utilizing
current guidelines and updating inform ation in a multidisciplinary forum, nurses can
develop realistic, scientifically-based guidelines for ICD patients. To date, no study has
systemically analyzed clinical conditions as risk factors predisposing patients to an
inappropriate shock, and the phenom enon remains relatively unexplored. As nurse
scientists, advanced cardiovascular nurses are taking leadership roles in major
interdisciplinary organizations and need knowledge and skills to contribute in a
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competitive, ever-evolving field. Therefore, it is imperative to investigate the clinical
characteristics o f ICD patients that may be predictive o f inappropriate shock in a broad
population.
Purpose o f the Study
The overall purpose o f this study was to describe the incidence o f appropriate and
inappropriate shock occurrence and to investigate the clinical predisposing factors for an
inappropriate shock in a group o f ICD recipients treated at a university medical center in
Southern California during the period from July 2000 to May, 2005. The specific aims
were as follows:
Specific Aim # 1
To describe the incidence o f appropriate and inappropriate shock occurrence in a
group o f ICD recipients who visited the university medical facility between July, 2000
and May, 2005 for emergent and routine follow-up visits.
Specific Aim # 2
To describe the relative risk relationships between age group and 1ST, gender and
1ST, heart disease severity and 1ST, structural/ non-structural heart disease and 1ST, and
the history o f atrial fibrillation and 1ST.
Specific Aim # 3
To describe the frequency o f ISTs in a group o f ICD recipients by risk factors (e.g.,
atrial fibrillation, lead problems, double counting) and the frequency and proportion o f
each risk factor associated with an 1ST.
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Specific Aim #4
To investigate significant correlations between clinical factors and an 1ST, and,
when taken in combination, to reveal any clinical predictability for the incidence o f an
1ST. Clinical factors analyzed include demographic characteristics, history o f previous
underlying heart disease, ejection fraction, and medications taken at the time o f the 1ST.
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CHAPTER II
REVIEW OF LITERATURE
Inappropriate shocks from ICD therapy occur in a combination of events
involving the interference o f the patient, device and environment. Regarding the causes
o f 1ST, it is imperative to understand the foundation it is built upon. For this reason, the
author has scrutinized the pathways that lead to 1ST.
This section begins with a review relevant arrhythmias of implantable
Cardioverter-deflbrillator. The concepts o f reentry and defibrillation are discussed,
because they play important roles in the events o f 1ST. The author then proceeds to
discuss the development o f ICD, its multiprogrammable features and the function o f this
modem device. This section concludes with the significance o f interrogation concerning
ICD in follow-up visits.

The Relevant Arrhythmias o f Implantable Cardioverter -D efibrillator Therapy:
Supraventricular Arrhythmias
Supraventricular Tachycardia.
Supraventricular tachycardia (SVT) is a rapid, regular heart rate, where the
heartbeat ranges from 150 to 250 beats per minute in the atria. The condition can be
caused by a number o f factors, or it can occur spontaneously. As a result, the heart beats
abnormally fast and the oxygen supply to the brain is reduced. Some people experience
no symptoms, yet others may experience dizziness, syncope, shortness o f breath, pale
color, chest tightness, and chest pain (Ganz, 2002).
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Atrial Fibrillation
Electrical signals in the atria are fired in a very fast and uncontrollable manner.
Atrial signals create a pattern o f rapid and chaotic beating that starts at 350 beats per
minute and ranges higher. Instead o f a single electrical signal followed by coordinated
atrial contraction, there is quivering o f the atrial muscle. Not all signals are conducted
through the AV node. Ventricular rates m ay vary from 100 to 180. Atrial fibrillation (AF)
may occur in a sustained manner or may occur episodically (Woods, Froelicher, Motzer,
& Bridges, 2005).
Ventricular Arrhythmias
The two m ajor types of the ventricular arrhythmias are ventricular tachycardia (VT)
and ventricular fibrillation (VF). VT is a regular heartbeat arising in the ventricles.
Ventricular fibrillation occurs when the ventricles go out o f control, quivering and
beating ineffectively, thereby stopping the pum ping action. If a more normal rhythm is
not restored promptly—within three to five m inutes— the patient will suffer brain and
heart damage and will die (Kastor, 2000; Woods, Froelicher, Motzer, & Bridges, 2005).
Ventricular Tachycardia.
Ventricular tachycardia occurs when the ventricles produce impulses that make the
heart beat too quickly. With this disorder, the heart tries to beat 150 a minute or more.
The heart does not fill with enough blood betw een beats to meet the body's needs.
Symptoms include a pounding sensation, dizziness, and sometimes fainting occurs
(Kastor, 2000). There are several categories that VT falls under. Please see Table 1.
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Table 1
Ventricular Tachycardia Defined by Category
Category 1
Duration / Duration o f Tachycardia
Transient also called
Beats are no longer than 30 seconds, with a minimum o f 3
unsustained or nonsustained
consecutive ventricular beat and without cardiovascular
(NSVT)
deterioration.
Sustained in which the
More than 30 seconds, with cardiovascular deterioration,
paroxysms last (SMVT)
requires immediate treatment to prevent cardiovascular
collapse.
Incessant
Most o f the time.
Category II
Electrocardiographic Appearance / QRS Form
Monomorphic ventricular
Each o f the QRS complexes has identical or nearly
tachycardia
identical.
Polymorphic ventricular
The morphology (form) o f the QRS complexes change
tachycardia (also called
A particularly rapid, dangerous form o f VT that often
Torsade de Point, TdP)
occurs as a result o f certain medications or in patients with
congenital Long QT syndrome.
Category III
The Presence or Absence o f Heart Disease/ Examples
With heart disease
most often coronary or cardiomyopathic
Without structural heart
Long QT syndrome, Brugada syndrome, short QT
disease or idiopathic.
syndrome.
Source: Modified from Kastor, . A. (2000). Arrhythmias. (2nd). Philadelphia : W. B.
Sunders, p.343.
Ventricular Fibrillation
Ventricular fibrillation (VF) is a chaotic heart rate resulting from multiple areas o f
the ventricles attempting to control the heart's rhythm. VF sometimes can occur
spontaneously, but generally it is caused by heart disease, or when VT has persisted too
long. When the ventricles fibrillate, they cannot contract normally, hence, they cannot
effectively pump blood. The instant VF begins, effective blood pumping stops. VF
quickly becomes more erratic, resulting in sudden cardiac arrest or sudden cardiac death.
This arrhythmia must be corrected immediately via shock from an external defibrillator
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or an ICD. The defibrillator can stop the chaotic electrical activity and restore normal
rhythm (Ganz, 2002; Kastor, 2000).

Mechanisms o f Fibrillation and Defibrillation
The Role o f Reentry
The available clinical and experimental evidence suggests that instability in VT
leading to the degeneration o f the VT into VF is a phenomenon o f re-entry, which is a
disorder o f impulse conduction (Singer, 1994). The restitution hypothesis suggests a
mechanism for the development o f instability in re-entry that may explain the
predisposition for degeneration to fibrillation (Adgey, Spence, & Walsh, 2005; Spector,
2005).
Re-entry is a continuous electrical activity in which each wave re-circulates to
produce the next wave. For activation waves to propagate continuously, two paths for
conduction separated by unexcitable tissue are required. Activation must spread around
one side o f the unexcitable tissue allowing the other side time to recover from
inactivation in order to re-excite the tissue when the wave front returns. Tissue refractory
periods limit re-entry: the conduction time around the circuit must be greater than the
refractory period o f each component o f the circuit. Therefore, decreased conduction
velocity or a decreased refractory period facilitates re-entry by decreasing the likelihood
that the activation wave front will encounter its own refractory tail, ending the
tachycardia (Woods, Froelicher, Motzer, and Bridges, 2005)
In clinical practice, re-entrant circuits can occur in two circumstances. First, a
fixed re-entry is the site o f an anatomic conduction block that resulted from scar tissue
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and frequently occurs in the setting o f ischemic cardiomyopathy (Adgey, Spence et al.,
2005).
The second circumstance during which functional re-entry may occur is in the
absence o f anatomic obstacles. In this instance, the circuit path is determined by tissue
refractoriness. Factors leading to the correct conditions that favor such re-entry
mechanisms include increased heart size through hypertrophy or dilatation, drugs that
alter the length o f the refractory period, and areas o f cardiac disease. A group of
transiently unexcitable cells (i.e., secondary to refractoriness) creates an obstacle to the
conduction around which a circuit can form (Adgey, Spence et al., 2005).
The Electrophysiological Concepts o f Ventricular Defibrillation
The mechanism o f ventricular defibrillation has been extensively investigated over
m any decades. However, the definite mechanism o f defibrillation is still unclear and
m any hypotheses have been proposed. The most influential was the critical mass
hypothesis. First proposed by Garrey in l9 1 4 (Spence, 2003), it was supported by several
other electrocardiologists. Garrey found that a fibrillating heart would no longer fibrillate
when the myocardial mass decreased into small pieces (Adgey, Spence et al., 2005). The
studies from Schunder, Stoekle, Gold, West, & Denniston (1973) and Miroski, Mower,
Gott, Brawley, & Denniston (1973) showed that successful defibrillation could occur
when low energy shocks were delivered though a transvenous catheter. This result
suggested that the shock might need to defibrillate only the critical mass o f the ventricles
to get a successful outcome. In 1975, Zipes, and his colleagues provided further
validation for this idea by demonstrating that the chemical depolarization o f a critical
mass o f ventricular myocardium (-75% ), using selective infusion o f potassium chloride
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into the left coronary artery, would successfully abolish ventricular fibrillation. Therefore,
if a sufficient voltage potential gradient could be generated by a shock to halt the
fibrillation activation fronts in the myocardium, defibrillation could occur (Adgey,
Spence et al., 2005).

Historical Development o f the o f Defibrillator
Development o f practical defibrillators began in the 1920s with response to an
increasing number o f electrical shock accidents and deaths. In 1947, Beck et al.
performed the first successful human defibrillation using specially designed internal
cardiac paddles to resuscitate a 14-year-old boy who had become pulse-less during
elective chest surgery. In 1956, Zoll et al. performed the first successful human external
defibrillation using a 15-amp AC current that produced 710 volts applied across the chest
for 0.15 seconds. In 1961, Alexander, Kleiger, and Lown first described the use o f AC
current for terminating VT. Work by Lown et al. in the early 1960’s demonstrated the
superiority and safety o f DC over AC for defibrillation. Ambulance-transported Belfast
physicians first performed successful pre-hospital defibrillation in 1966. Defibrillation by
emergency medical technicians (EMTs) without the presence o f physicians was first
performed in Portland, Oregon, in 1969 and was reported in 1972. (Bocka, 2005)
The Implantable Cardioverter Defibrillator
In the 1960s, Mirowski (1985) conceived o f the idea o f an automatic implantable
defibrillator. The first ICD was implanted in a young woman as a prophylaxis against
SCD in 1980. The U.S. Food and Drug Administration approved the device in 1985.
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The earliest devices weighed up to 300 grams, had a battery life o f three years,
and were implanted in the subcutaneous layer o f the abdomen with epical screw-in leads,
and were sutured to the pericardium (Wolfe, Kosinski, & Grubb, 1998). A second
generation o f devices, developed in the mid-1980s, did not require thoracotomy, but used
a transvenous defibrillating lead. These second generation ICDs employed cardioversion,
were programmable, detected ventricular arrhythmias better, and delayed electrical
therapy. In the 1990’s, the third generation ICDs had multiple features, tiered therapies,
enhanced programmability, and increased sophistication, as well as being designed to
target energy delivery. Additionally, these advanced devices weighed less than 40
milligrams and had a battery life o f eight years (Fetzer, 2003).
Components o f Current ICDs
The current ICD consists o f a pulse generator and one or more leads. An epoxy
resin header at the top of the generator connects pacing and defibrillation electrodes
(DiMarco, 2003; Zipes, Libby, Bonow, & Braunwald, 2005).
The newer models provide a daily rhythm history with as many as 150 certain
therapy events stored in their memory. The devices that store a graphic image o f a
patient’s arrhythmia, called an electrogram (EGM), are ready for interrogation by an
external analyzer. However, if events go beyond the capacity o f storage, the oldest
rhythm would be discarded and the newest would be stored instead (DiMarco, 2003).
An ICD battery usually functions between four and eight years, depending on the
number of shocks and/or the pacing it sends. W hen the battery runs down, a new ICD
must be implanted (DiMarco, 2003; Fetzer, 2003; Zipes, Libby, Bonow, & Braunwald,
2005).
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The leads are responsible for capturing the electrical activity that goes toward
internal sensing, provide a site for pacing and defibrillating. Recent technological
improvements in electrode design have led to improved features. The transvenous leads
have decreased the amount of energy required to defibrillate. This decrease in energy has
rendered the need for the larger epicardial patches and electrodes rendering sternotomy
incisions obsolete. Therefore, these transvenous leads are now accepted as a standard
(Seidl & Senges, 2003). Currently, the following models are available: (a) a single
chambered, ventricular-only device that is usually placed in the right ventricle; (b) a dual
chambered atrial and ventricular device with leads placed in the right ventricle and atrium;
and (c) a biventricular ICD, whose leads are attached in the right atrium, the right
ventricle and the left ventricle. These techniques help the heart beat in a more balanced
way and are specifically used for patients with heart failure.
Functions o f Implantable Cardioverter-Defibrillator
The ICD has three major functions: monitoring, detecting and delivering. The
ICD program monitors the R wave o f the electrocardiogram and counts the num ber o f
QRS complexes per minute on a beat-to-beat basis (Fetzer, 2003). The ICD determines
when the ventricular rate exceeds the programmed limit. Many ICDs have a VT zone
(e.g., 150-200 beats per minute [bpm]) and a VF zone (e.g., > 200 bpm). W hen the ICD
has detected the ventricular rate and QRS morphology abnormalities that exceed its
programmed limits, the program triggers the antitachycardia pacing therapy (ATP).
When the heart beats too fast, a series o f small electrical impulses are delivered to the
heart muscle to restore a normal heart rate and rhythm for VT, or delivers a shock to
terminate VF (Clemo & Ellenborg, 2001; DiMarco, 2003).
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When the shock program has been initiated, the device can be programmed to
deliver a first shock from a minimum o f 1 joule to a maximum o f 41 joules, depending on
the energy level required; traditionally starting at 10 joules. The charging time can take
0.1 to 7 seconds. After delivering the first shock, a 5 to 25 second delay is programmed to
allow the ICD to detect any continuing dysrhythmia and recharge. Second, third, fourth,
and fifth shocks are delivered at the maximum energy level if needed. Newer ICD models
can be programmed for six shocks, and some will deliver a maximum o f eight shocks.
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Appropriate shock is defined as an ICD delivered discharge (shock) at the presence o f VT or VF
Inppropriate shock is defined as an ICD delivered shock at the absence of VT or VF, usually with no preceding symptoms.
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Appropriate Shock vs Inappropriate Shock
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Interrogation o f the ICD
The interrogation procedure is typically done every three months in a specialized
pacemaker/ICD follow-up clinic. A cardiac electrophysiologist, assisted by a trained
technician or senior cardiovascular nurse, performs the procedure. Interrogation is also
performed as the device approaches elective replacement or in response to symptomatic
events (e.g., shocks).
During ICD interrogation, a “wand” is passed over the device and is attached to a
programmer for communicating by means o f electromagnetic coupling. Thus, the
electrophysiologist is able to determine what electrical therapies have been experienced.
The interrogation process checks lead integrity and battery status. Based on the revealed
information, the device can be adjusted to optimize detection and therapy parameters.
Most ICDs record the patients’ electrocardiographic tracing at the time of arrhythmia
detection. This information can be analyzed at follow-up visits to determine the nature o f
the arrhythmia and the efficacy o f the electrical therapy that was given (Groh & Foremn,
1998).
An implantable defibrillator, prescribed for people whose hearts beat dangerously
fast, operates differently from a pacemaker. W hen a defibrillator detects a fast heart rate,
it delivers electrical therapies to restore a normal rhythm. Depending on the patient's
condition, these therapies can begin m ildly and becom e progressively stronger as needed
(ATP). The highest energy therapy is called defibrillation, and it provides treatment
similar to defibrillation paddles used by medical personnel (Fetzer, 2003). Over 250,000
defibrillators have been implanted worldwide since 1985 (Metronic, 2005).
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Review o f Literature on Inappropriate Shock
The ICD has achieved a preem inent role in the treatm ent o f life-threatening,
ventricular arrhythmias. The m ost common arrhythm ias-related com plaint among ICD
patients is the subjective feeling o f shock. The variant causes o f inappropriate shock
therapy rem ains a m ajor clinical problem and the contributing factors rem ain unclear.
Weber, Boecker, Block(1996) reported that the causes o f 1ST are many, including: AF,
the m ost frequent cause o f 1ST; lead over sensing due to lead failure; sinus tachycardia;
problem s with environm ental interference; and other unknow n factors. Studies in which
the incidence o f ISTs has been exam ined have docum ented single, multiple, or repetitive
shocks from a variety causes in ventricular ICDs. However, studies investigating atrial
ICDs that cardiovert atrial fibrillation with a slow ventricular rate are no longer available
and are beyond the scope o f this review. Therefore, the topic o f atrial ICDs will not be
addressed.
Overall Factors Contributing to 1ST
The first large scale study reviewed by Grimm et al. (1992), retrospectively
analyzed the incidence and causes o f docum ented cases o f spontaneous
electrocardiography (ECG), and ICD discharges in the absence o f VT and VF in 241
patients. During the follow-up period (24 ± 20 m onths), records o f electrogram storage
demonstrated that 54 o f 241 patients (22%) received a total o f 132 spontaneous ICD
charges in the absence o f VT or VF. The researcher further found that the most frequent
cause o f these ISTs was AF w ith rapid ventricular response (n = 30 patients). ISTs caused
by lead problems occurred in eight patients. The rest o f events o f 1ST were caused by
generator m alfunction VVI program m ing, and by T-wave oversensing.
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Nunain, Roelke, Trouton, Kim, Sosa-Suarez, and Brooks (1995) performed a
descriptive study examining the problem(s) o f third generation ICD therapy. One
hundred and fifty-four patients with monomorphic sustained ventricular tachycardia
(MSVT), VF, or syncope, with inducible VT not suppressed by antiarrhythmic drug
therapy, and implanted with ICDs, were recruited for the study. In the mean follow-up
period (15.3 ± 9.7 months), 30 o f 154 patients had non-thoracotomy lead systems. The
26% rate of 1ST was similar to that reported for an earlier generation (Grimm et al., 1992).
Thirty-two patients (21% o f subjects) received ISTs for either sinus tachycardia or AF
with rapid ventricular response. In this study, AF remained the primary cause o f 1ST, with
lead problems as the second major cause (n = 3). Nunain et al. acknowledged that the
success of ATP therapy could reduce the need for shock in the third generation ICD
device.
Klein, Raitt, and W ilkoff (2003) expanded the number o f subjects to evaluate the
incidence and characteristics o f arrhythmia events that triggered ICD therapy in the
Antiarhythmics Versus Implantable Defibrillator (AVID) Trial. Four hundred ninety-two
of 1016 participants in this trial were examined. The results demonstrated that
inappropriate sensing, ICD malfunction, and electrode failure rarely triggered ICD
therapy in the AVID trial. AF and other sustained ventricular tachycardia (SVT) were
responsible for attempted therapy in 11 patients and for all 13 treated episodes. Patients
who received 1ST were slighter younger (63 ± 11 vs. 66 ± 11, p < .05). Since
approximately one-third o f all patients in the AVID Trial received no syndrome preceding
the delivery o f the therapy, Klein et al. concluded that clinical or electrophysiologic
parameters could not predict 1ST accurately.
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A prospective study, conducted by Russio, Nayak, Yerdino, Springman, Tenfeld,
et al. (2003), exam ined the occurrence o f ICD shock events in 51 patients (Mf0ii0W-up = 16
months). 1ST occurred in four patients. Shock therapy was delivered for SVT in four
patients; one 1ST delivery was related to AF; and one 1ST was related to T- wave
oversensing. Russio et al. concluded that the low incidence o f 1ST (8% ) might be related
to vigilant device program m ing. However, the follow-up period utilized in this study was
limited.
Nanthakum ar, Dorian, Paquette, Greene, Edwards, Heng, et al (2003)
retrospectively analyzed the single cham ber ICD s’ recipients w ith a history o f AF or
NYHA Class I to identify patients most at risk for receiving inappropriate shock. O f 299
patients, 261 com pleted data for analysis. All received ICDs in 1990 using single
chamber, third generation, tiered device therapy. Results confirm ed that 116 o f the 261
patients (44%) received one or more inappropriate therapies and 73% o f patients received
inappropriate therapies w ithin 2 years o f receiving their device. The causes ISTs were: (a)
ST = 58 (50%); (b) AF = 38 (33%); and, (c) noise events = 20 (17%). Seventy-one
percent o f the patients received shocks within two years o f device implantation.
Significant predictors o f inappropriate therapy with AF and N Y H A Class 1 versus Class
II- IV. Age, gender, and coronary artery bypass graft (CABG) did not increase the risk o f
receiving an 1ST. The type o f m edications taken upon hospital discharge was also not a
predictor of events. N anthakum ar et al. supported the suggestion that ICD recipients with
a previous history o f AF should be considered “at risk” for the occurrence o f 1ST.
However, the hypothesis that NYHA Class I should not be considered a risk factor, since
the development o f 1ST rem ained unsupported.
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Recently, Rinaddi, Simmon, Bostock, Elliot, Bcknall, and Gill (2004) intended to
assess whether the occurrence o f 1ST would be reduced by the diagnostic enhancements
o f the ICD device. Rinaddi et al. retrospectively analyzed the data from 171 patients over
17 years of 1ST experience. Based on the records with full data (n =155 patients), results
showed that 1ST occurred in 22 patients (14%), predominantly for atrial arrhythmias (18
patients with 1ST for atrial flutter/AF or ST). The occurrence o f 1ST in the remaining
four patients was related to problems with lead fractures. The three independent
predictors o f 1ST identified by these researchers were pre-existing atrial tachyarrhythmias,
co-existent medication therapy, and a single cham ber device. Data also showed dilated
cardiomyopathy (DCM) and high incidences o f 1ST (50%). AF incidence was also high
(80%) and in high proportion (78%). Rinaddi et al. stated that the finding o f increased
coexistent medication therapy was not entirely clear, but m ight reflect poorer left
ventricular functioning that is often associated with an enhanced use o f medication
therapy. Similarly, AF itself might be predisposed to ventricular arrhythmias. As for
DCM patients, the researchers posited that the high incidences o f 1ST were likely related
to their increased incidence o f AF.
Most recently, a prospective study by Theuns, Klootwijk, Simoons, and Jordaens
(2005). collected clinical and functional variables for each patient. This study evaluated
whether clinical characteristics could predict inappropriate ICD therapy due to atrial
tachyarrhythmias. The observations noted in this study were: (1) a history o f atrial
tachyarrhythmias is an independent predictor o f inappropriate therapy; and (2) recurrent
VT with a C33L >350 ms that triggered device therapy was associated with an increased
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risk for first inappropriate therapy. However, this study was not thorough enough to
adequately to address the clinical associates.

Individual Factors
Lead Failure and Related Problems
Dorwarth, Frey, Dugas, Matis, Fiek, Schmoeckel, et al. (2003) retrospectively
analyzed the incidence and clinical presentation o f transvenous ICD lead failures during
long-term follow-up and their clinical mode o f presentation (n = 261). These patients had
a transvenous ICD lead systems that were implanted between 1990 and 1998. Seventy
patients had an implantation site on the abdomen, whereas 191 patients had implantations
on the pectoral site. Patients who had experienced lead dislodgement were excluded. The
results demonstrated that 31 o f 261 subjects’ lead malfunction had inappropriate detection,
with 1ST occurring in 19 of 31 patients who had received 1 to 11 shocks. A high number
o f malfunctions (48%) was observed within the first year after device replacement due to
battery depletion, with battery depletion occurring after 4.6 ± .07 years. Dorwarth et al.
recommended that clinicians carefully monitor the lead status in any ICD recipient with a
transvenous lead for more than four years.
Lead Hyperpolarization
Healy, Goyal, Browing, Robotis, Ramaswamy, Rofino-Nadoworany, et al. (2004)
did a case study o f another aspect o f a lead problem. The patient involved did not
experience any symptoms prior to being first shocked 16 months after implantation. He
received the shock at a time when he was climbing the stairs. The initial shock occurred
after an AF provoked an episode o f VF. This VF was terminated by an appropriate shock,
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but due to lead hyperpolarization and T wave oversensing, the device continued to deliver
five inappropriate therapies at 30 joules. The mechanism behind this phenomenon was
unclear, but might have involved an interaction at the lead/myocardium interface at the
time this patient climbed the stairs. Healey, et al. proposed that the mechanisms for
proarrhythmic effects o f shock might be caused by an increase in QT dispersion.
Increasing sotalol from 40 mg bid to 80 mg bid resulted in no further shocks.
Lead Connection: Header and Set Screw-Related Problems
Picket, Saaverdr, Ali, Darbar, and Rottman (2004) reported four cases (i.e., three
males and one female) o f device malfiinction due to the mechanical failure o f a header
connection within the a single device family over a limited time. The patient in Case 1
received one shock on the day after the procedure and 15 shocks occurred three days post
implantation within one and a half hours. Repeated chest X-rays revealed an incomplete
penetration o f the right ventricular term inal pin in the header. Two ISTs occurred in
Patient 3 as the left ventricular lead could not be placed due to increasing dyspnea at the
time o f implantation. After the device was replaced, no further problems were reported.
The other two patients, as described by Picket et al., did not receive any ISTs. These
cases shared a common element o f defective connections between the header post and the
right ventricular pace/sense terminal pin that required intervention and reconnection.
Picket et al. posited that such lead connection problems would increase as ICD devices
became more complex.
Double Counting
Biventricular pacing emerged as a modality for the treatment o f patients with
heart failure. Combined biventricular pacers and ICDs offered treatment for heart failure
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as well as protection from a sudden cardiac death. Tachycardia detection in firstgeneration biventricular pacemaker-implantable cardioverter defibrillators (BiV ICD)
occurred through both the right ventricular (RV) and left ventricular (LV) leads, creating
the potential for inappropriate detection and therapies (Al-Ahmad, Wang, Homoud, Estes,
and Link, 2004).
Case studies done by Schreieck, Zrenne, Kolb, Ndrepepa, and Schmitt (2001) and
Liu, Villareal, Hariharan, Rasekh, and Massumi (2003) presented three patients who had
all received 1ST from biventricular ICD therapy. Al-Ahmad, Wang, Homoud, Estes, and
Link (2004) performed another study related to the problem o f double counting. AlAhmad et al. retrospectively analyzed the ICD records from a group o f 23 patients
receiving biventricular ICD therapy. Within the follow- up period (3.7 ± 2.6 months), the
results showed that 15 ISTs out o f 33 shocks in five patients were caused by double
sensing. All episodes resulting in shock occurred because o f sinus tachycardia or a
supraventricular tachycardia (SVT) higher than the upper-programmed pacing rate o f the
device with resultant AV conduction and double sensing o f the non-paced ventricular
depolarization. Al-Ahmad et al. concluded that double sensing o f the R-wave was a
common and clinically important cause o f inappropriate ICD detection and shock in
patients with biventricular ICDs. New generation devices with inappropriate detection in
patients with a first-generation BiV ICD was common and often resulted in inappropriate
ICD therapy. The most common mechanism o f inappropriate detection was double
counting, often creating the need for additional procedures. Although devices in which
tachycardia detection occurred only through the RV lead were now available, RV/LV
output and double counting should therefore not occur. However, close follow-up o f the
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patients who received a first-generation BiV ICD was necessary (Chugh, Scharf, Hall,
Cheung, Good, Horwood, et al., 2005)
Generator Malfunction Issues
Generator malfunction constitutes another type o f device limitation that could also
cause an inappropriate shock. De M eester and Gilles (2001) reported a case study o f 1ST
that related to the ICD malfunction caused by excessive defibrillation o f charge time
>

twice (22 seconds and 19 seconds). Suspected were the gradual decline in battery voltage
and increase o f battery resistance, and the consequence o f excessive charge time of the
electric capacitors device was affected by highly variable and ineffective capacitors.
Therefore, a new generator was implanted. De M eester and Gilles stated that, to avoid
similar events from recurring, long-term follow-up would be needed to investigate the
predisposing factors related to a malfunction o f the capacitor’s elements. Because o f this
potentially serious effect, the manufacturer recommended that ICDs with a charge time
longer than 14 seconds should be monitored every month. They also suggested that, if a
charge time exceeded 60 seconds, an immediate replacement was needed.
Diaphgram Myopotential
Three case studies were reported by Peters, Cooklin, Brockman, Steven,
Shorofsky, & Michael, (1998). The patient in case 1 had received all asymptomatic
shocks, which were not triggered by VT. But noise and oversensing were present during
normal sinus rhythm (NSR) at a moment when the subject was performing the Valsalva
maneuver. A fter decreasing the sensitivity in the device, the researchers noted that no
further shocks occurred in the ensuing month o f follow-up. Peters et al. stated that in all
three cases, the lead was initially positioned in the right ventricular apex. It is presumed

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1ST in patients with ICDs 30
that the sensing o f diaphragmatic potentials was directly related to the proximity o f the
lead to the diaphragm. Peter et al. also recommended that the possibility o f sensed DMP
should be considered at the time o f ICD implantation, especially during ventricular
pacing, so that the appropriate preventive measures can be taken.
In a larger prospective study, Schulte, Sperzel, Carleson, Dursh, & Erdogan, et al
(2001) investigated the incidence o f diaphragmatic myopotential (DMP) in a cohort of
384 ICD recipients from 1991 to 1999. One hundred and thirty-nine nonadequate
episodes o f arrhythmia due to the oversensing o f diaphragmatic myopotentials were
observed in 33 out of 384 patients. Eleven out o f these 33 patients had a total o f 32 high
energy shocks. The majority o f nonadequate arrhythmia detections were during intrinsic
bradycardia pacing. Electrical lead failure was ruled out in every patient. In 90% o f ICD
recipients provided with programmable maximal sensitivity (n = 16), the reduction of
maximum sensitivity was effective in preventing further episodes o f nonadequate
arrhythmia deduction. Schulte et al. recommended that the clinical use o f provocation
maneuvers to examine the oversensing o f DMP, (i.e., using the induction of DMP
oversensing to distinguish far field oversensing from electrical lead failure,) can prevent
an unnecessary surgical lead revision.
Electromagnetic Interference
Anfinsen, Bemsten, Kongsgaard, & Amlie (2002) reported the experience o f an
ICD recipient who had been implanted with an ICD endocardial lead post MI with VF.
Two ISTs occurred during an MRI o f the brain in this patient. These authors proposed
that electromagnetic noise induced during the MRI m ay be detected as VF and
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subsequently cause 1ST. Anfmsen et al. Suggested that clinicians should consider
inactivating the ICD before an MRI procedure.
Anifinsen et al. went on to describe EMI occurring in four other patients with
ICDs. Patient A received one shock while she was cleaning a lamp that connected to a
230 V 50Hz alternating current. Patient B received an 1ST when he was using a vibrator
for genital and anal stimulation. Patient C experienced two ISTs while being treated by
electronic muscle stimulation o f the gluteal region. Patient D was using a percussion drill
when he experienced two episodes o f VF detection during sinus rhythm.
The incidence o f 1ST caused by EMI has been estimated as < 1% per patient/per
year (Kolb, Zrenner, and Schmitt, 2001). However, some episodes may have gone
undetected. Thus, the overall incidence o f EMI m ight be underestimated in the literature.
The improvement o f EMI detection algorithms and advances in lead technology are
necessary to minimize the risk o f EMI-related 1ST in ICD patients.
The interference between ICD function and the use o f a washing machine was
documented by Chan and Ho (2005). These authors also reported an instance o f 1ST
occurring when a subject wore a pair o f cotton gloves to operate a power drill during a
rainy day. Therefore, Chan and Ho suggested that EMI due to 50 Hz alternating current
leak could be avoided by giving detailed advice on the handling o f electrical appliances
to ICD recipients.
D rug Interactions
The concomitant administration o f antiarrhythmic drug therapy remains common
in patients with ICD. The potential influence o f antiarrhythmic drugs on the defibrillation
threshold (DFT) is the most significant issue. Class III agents (except amiodarone) can be
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safely administered in conjunction with ICD patients as long as the interaction between
these therapeutic modalities is monitored (Sergo, & Gerard, 1995).
Due to the psychological impact o f ICD therapy, patients with these devices often
had symptoms o f anxiety or depression (Dougherty, 1995, Burg, Lampert, Joska,
Batsford, & Jain, 2004). Pickworth, Votolato, and Raman (2004) reported a 35-year-old
woman with depression. After implantation, the ICD was tested by delivering a shock on
the T wave to induce VF. It was not terminated by one 15 joules and one 20 joules shock,
but terminated by an additional seven external shocks o f 360 joules. After evaluating the
patient’s drug regimen, a suspected drug to device interaction was discovered between
Venlafaxine and ICD. After discounting Venlafaxine, an antidepressant with cardiac
sodium, channel blocking activity was identified as a potential contributor to her elevated
defibrillation threshold. The ICD was able to successfully defibrillate the patient. Camers
et al. (2004) suggested that clinicians should be aware o f this potential adverse drugdevice interaction. Further studies are needed to determine the clinical significance o f
Venlafaxine therapy in patients with ICDs.
In a case reported by Mcbride, & Klucger (2004), an ICD recipient consumed two
to three doses o f Metabolife 356, a dietary weight loss supplement. The patient received
four ISTs within 3 days. Device interrogation revealed atrial tachycardia. The patient
stopped taking Metabolife 356 and took increasing doses o f Sotalol instead. The patient
remained event free for 18 months. The researcher suspected that the Metabolife 356
induced atrial tachycardia resulted in multiple discharges. This author proposes that ICD
recipients concomitantly consuming alternative pharmacotherapy m ay have an enhanced
risk o f inappropriate ICD functioning.
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Clinical Characteristics and Other Factors
Authorities propose that 1ST is most often the result o f SVT, lead/device
malfunction, or oversensing. Other situations leading to the occurrence o f 1ST have been
reported as well (Healy, Ngarmukos, and Rosenthal, 2002).
Healy, Ngarmukos, and Rosenthal (2002) described a case experiencing an 1ST
associated with improper timing. This 58 year-old man with a history o f ICM underwent
ICD implantation after having an EPS positive for inducible SMVT. One 1ST occurred at
one week post implantation. Electrograms revealed that a run o f NSYT had caused the
ICD to charge. The device appropriately detected the rhythm abnormality and charged.
However, after charging, a premature ventricular contraction (PVC) with a short coupling
interval was detected during the second look window and a shock was delivered to the
patient while in sinus rhythm. Thus, Healey et al. stressed that while algorithms are being
developed to deliver appropriate therapy for life-threatening ventricular arrhythmias, an
algorithm that allowed for continued sensing during the charge period might have saved
this particular patient.
Recently, it has been proposed that a congenital short QT interval is associated
with an increased risk for arrhythmias and SCD (Schim pf et al, 2003). At present, the
ICD is the only therapeutic option. Schim pf et al. recruited five patients from two
unrelated European families who had structurally normal hearts, excessively shortened
QT intervals, and strong positive family history o f SCD. ICDs were placed for primary
and secondary prevention. Mean QT intervals were 252 ±13ms (QTc 287±13 ms). In the
follow-up 30± 26 days, Schim pf et al. observed that three o f five patients received ISTs
for T wave oversensing. After reprogramming their generators o f ICDs by lowering

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1ST in patients with ICDs 34
sensitivities, no further episodes o f 1ST were noted. Schimpf et al. concluded that an
increased risk for 1ST is inherent, due to the detection o f short-coupled and prominent T
waves.
Idiopathic VF patients had a high recurrence rate o f ventricular arrhythmias. ICD
prevented SCD from this population; the clinical outcome o f the ICD recipients with
solely a diagnosis o f Idiopathic VF was lacking. Champagne, Geelen, Philippon, and
Brugada, (2005) conducted a prospective cohort study (from 1992 to 2000) to examine
the clinical and electrophysiological characteristics o f consecutive SCD survivors from
idiopathic VF. In this study, after excluding those patients with LQTS, Brugada syndrome,
right ventricular dysplasia and no history o f CAD from 445 ICD recipients, 18 patients
with idiopathic VF were studied. Six participants had syncope associated with self
terminated TdP or VF, and 12 subjects survived an episode o f SCD with VF. All of the
subjects had left ventricular ejection fraction o f >50% and a mean age o f 42 (ranging
from 20 to 70). At the mean follow-up at 41± months, 7 out o f 18 patients received a total
of 27 shocks, and 8 o f 18(44%) subjects received 1ST for a total 21 discharges. The
causes included AF in l2 o f 21 (57%) episodes in 14 patients (mean age 53±14 years);
sinus tachycardia in 6 o f 21 episodes in 4 patients (mean age o f 31±13 years); lead
malfunction 3 o f 21 episodes in 2 patients (mean age unknown); and 6 o f 21 episodes in 2
patients had experienced 1ST from AF. Data also demonstrated that the presence of the
ICD prevented SCD from idiopathic VF, and only treated the final manifestation o f
unknown diseases. 1ST remained a major concern in this young population.
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Death Events Related to Inappropriate Shock Therapy
Messali, Thomas, Chauvin, Conmel and Leenhardt (2004) reported that the cause
o f death of one ICD recipient was related to 1ST. This patient was a 49 year-old man,
with a 15-year history o f NIDCM and an LVEF o f 40%. The patient had a history o f two
cases o f SCD and DCM in his immediately family. A syncopal SMVT was performed in
1991, with an initial ICD implantation in 1991 in the abdominal site. The generator was
replaced in 1995 and in 2000, but the same atrial and ventricular leads from the original
ICD implantation were retained. This patient received six shocks and experienced SCD in
2000. Data storage o f the fatal event showed an episode o f ventricular oversensing during
sinus rhythm that was improperly designated as VF because o f some short cycle lengths <
300ms. This false detection triggered the first shock as well as five subsequent shocks
within two minutes. The sixth shock induced a true, untreatable VF. Inappropriate shocks
were delivered due to noise oversensing originating from a ventricular lead with an
insulation defect. In the interrogation o f the device, it was also revealed that the patient
had experienced an 1ST nine days earlier due to the same type o f oversensing and
multiple NSVT that might have been oversensing in the 12 days before death. Messali et
al. posited that the event o f noise oversensing could be caused by an insulation defect o f
the ventricular lead that was caused by prolonged used and repeated episodes of shock.
However, other studies have demonstrated that oversensing could have occurred without
structural lead failure (Dorwarth, et al, 2003). Therefore, the abdominal location and
coaxial body design may be predictors for long-term structural failure o f the ventricular
lead. Messali et al. emphasized the need for careful follow-up for patients with ICDs and
the performance o f interrogation as soon as possible following a shock delivery.
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A recent tragic event occurred, caused by a generator malfunction, to a 21 yearold college student with HCM, according to a m anufacturer’s report. An autopsy
revealed no clinically significant pathology beyond a massive left ventricular hypertrophy.
An ICD was shown to be almost successful in preventing SCD for this young man.
W hen the manufacturer analyzed the ICD, it was revealed that the device had shortcircuited internally while trying to deliver high voltage therapy, thereby permanently
disabling itself. Its memory had been destroyed, making the time o f failure impossible to
pinpoint (Gomic, Hauser, Almquist, Maron, 2005; Steinbrook, 2005). Since this defect
was not detected at the patient’s previous regular follow -up, the safety and the reliability
of these life-saving devices triggered a broad discussion. The FDA and Heart Rhythm
Society will plan to develop the guidelines regarding ICD recalls for manufacture notification standards and will decide when to replace the ICD devices.

Summary and Conclusions
Despite the rapid evolution o f the ICD device and algorithms designed to reduce
1ST, the reported incidence o f 1ST ranges from 5% to 20% and continues to be a major
problem associated with the use o f ICD. Although spurious discharges are most
commonly caused by supraventricular arrhythmias, especially AF, 1ST can be triggered
by device malfunction, such as lead failure due to battery depletion, and problems related
to header and set screw connections, double counting, lead hyperpolarization and
generators. Other factors, such as an oversensing o f diaphragmatic myopotential,
electromagnetic interference, and interactions between antiarrythmic medications and the
ICD device are also frequently reported by researchers.
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There is also a growing consensus that structural heart diseases, such as ischemic
cardiomyopathy and heart failure, which induce the development of AF, contribute to the
occurrence o f 1ST. In addition, non- structural heart diseases, such as T wave oversensing,
occurred in patients with short QT syndrome. In some situations, researchers suspected
the underlying pathology may contribute to 1ST, although the exact nature o f the
relationship o f cardiac pathology to 1ST remains to be explored.
As the above literature review demonstrates, current documentation o f the 1ST
phenomenon in ICD patients is limited to either case studies or descriptive research
investigations with mostly small numbers o f subjects. Hence, the knowledge base in this
area is at an initial stage. While it is a definite limitation that the proposed study is based
on single-case studies and limited research, it is an appropriate next step in the
development o f knowledge to examine further the factors which experts suspect may play
a significant role in contributing to the occurrence o f 1ST. Table 2 refers to the risk
factors o f 1ST in the above studies.
Therefore, given the available evidence regarding the complex factors
contributing to 1ST, the researcher has examined the incidence o f appropriate shock and
inappropriate shock occurrence and has investigated the clinical predisposing factors o f
inappropriate shock in a group o f ICD recipients from a major medical center located in
Southern California, which also serves as a tertiary referral hospital.
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Inappropriate Shock Therapy Events in ICD Studies with Varying Criteria (Studies are Chorological Order)

A. Overall Factors with AF as a Primary Cause
A uthor(s)
/year
Grimm
et al /1992

Subjects
(N = Total)
N = 241

Research
Design
Retrospective
Analysis

N unain
et al /1995

N =154

Descriptive
study

Nanthakumar
et al /2003

N =261

Retrospective
study

Finding (s) R/T 1ST # & Cause(s)
54 of 241 patients (22%) received a total 132 spontaneous ICD charges to the absence of VT
or VF
AF RVR:
30
Magnet misdirect
1
- T wave oversensing
1
- Generator malfunction
1
- Sensing lead malfunction 1
- Lead
1
- Loose set screw
1
- Lead adaptor break
1
• 1ST experience : 36 (28%)Patients
• AF : 32 (21%) SVT (AF or Sinus tachycardia) excess autogain in 2 patients.
•Lead p ro b le m : 1
116/261 patients received 1ST
• Causes:
- ST : 58 (50%),
-AF: 38(33%)
- Noise events: 20(17%)
• Predictors of increasing risk of receiving 1ST
-Previous Hx of AF &
NYHA Fcl received single chamber had high risk of develop 1ST 2-4 =1.3:1
•Age, sex, & CABG did not increase the risk of receiving 1ST
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Table 2

Russio
et al/2003

N = 492
from AVID
trail
N=51

Secondary
analysis

• AF and other SVT were responsible for attempting therapy in 22% of patients
• Patient received 1ST slighter younger (63 ±11 vs 66 ±11, p<.03).
• Approximately 1/3 of all patients received no syndrome preceding delivery of therapy

Prospective
study

• 1ST occurred in 4 patients.
• Causes of 1ST:
- SVA : 4 (8%)
- AF :1
-T wave oversensing : 1,
• 1ST : 22 (14%) patients
• Causes -Atrial flutter/AF, or ST: 18
- Lead fracture: 4
• 3 Independent predictors of 1ST - Pre- existing atrial tachyarrhythmias:
- Coexistent appropriate therapy
- 1ST more common with single chamber than double chamber
• DCM had high incidence of 1ST (50%). AF incidence was also high (80%) and high proportion
(78%)
1ST : 14%
Causes:
(1) a history o f atrial tachyarrhythmias is an independent predictor o f inappropriate
therapy and
(2) recurrent VT with a CL >350 ms that triggered device therapy was associated with an
increased risk for first inappropriate therapy.

Rinaldi
et al/ 2004

N=155

Retrospective
study

Theuns
et aI/2005

N=261

Prospective
study
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Klein,
et al /2003

A uthor(s)
/year
Dorwarth
et al/ 2003

Subjects
(N=total)
N = 261

Research
Design
Retrospective
analysis

Healey
et al /2004

N =1

Case Report

Pickett III
et al /2004

N=4

Case report

Finding (s) R/T 1ST # & Cause(s)
•31/261 subjects lead malfunction had inappropriate detection
•1ST occurred 19/31 patients
•3± (1-11) shocks /patient
X- ray did not show lead fracture in any of patient. Only one case had subclavian crush
syndrome. S/P the association with battery depletion secondary to old lead ( >4years)
-Initial 1ST AF
- the subsequently 6 ISTs : T wave oversensing secondary to lead hyperpolarization.
Case 1:15 shocks, -ray revealed incomplete penetration to the RV terminal pin in the header.
Case 2: no shock although it was found that the terminal pin penetration beyond the set screw
Case 3: Case 3- 2 ISTs due to the LV lead could not placed because of increasing dyspnea at
the time of implantation
Case 4 -no shock, terminal pin failed to extend beyond the set screw.
These cases shared a common element of defective connections between the header post and
the right ventricular pace/sense terminal pin that required intervention and reconnection

C. D ouble Counting
Author(s)
/year
Schreieck
et al /2001
Liu.
et al /2003
Al-Ahmad
et al/ 2004

Subjects
(N=total)
N= 1

Research
Design
Case study

N=3

Cases study

N = 23

Retrospective
study

Finding (s) R/T 1ST # & Cause(s)
An 1ST due to double detection of ventricular premature beats.
Case 1 - one 1ST occurred at 3 weeks after implantation
Case 2 - 4 ISTs occurred during 3 days after 2 weeks implantation.
Case 3 - one 1ST occurred 2 months after implantation
• 15 1ST /33 1ST episodes in 5 patients
• 7/33 (21.7%) due to double sensing.
• 4 patients(17.4%) had aborted shocks due to double sensing
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B. Inappropriate Shock Therapy Events in ICD Studies with Varying Criteria /Lead Problems

A uthor(s)
/year
De Meester
etal/2001

Subjects
(N=total)
N= 1

Research
Design
Case study

Healy
et al/ 2002

N = 1

Case study

Finding (s) R/T 1ST # & Cause(s)
•Two years after implantation Patient suffered from a recurrent syncope. Interrogation of the
device revealed ICD malfunction caused by excessive defibrillation charge time -22 seconds in
02/99 and 19 seconds in 03/99. * [manufacturer company recommend charge time of >14
seconds needs to be follow up every month].
One 1ST occurred at one week after implantation. Electrograms revealed that a run of NSVT
had ICD to charge. Further inspection revealed that a critically timed PVC during the "second
look" interval resulted in delivered therapy.

E. O versensing of D iaphragm atic M yopotentials
A uthor(s)
/year
Peters
et al /1998

Subjects
(N=total)
N=3

Research
Design
Case report

Schulte
et al/2001

N = 384

Prospective
study

Finding (s) R/T 1ST # & Cause(s)
Case 1-All several asymptomatic shocks were not triggered by VT.
noise & oversensing during NSR with deep inspiration & valsalva maneuver.
Case 2 - Received several shocks during AF & multiple arrhythmia detection’s during NSR at
the time of patient’s defecating.
Case 3 An asymptomic shock was demonstrated during valsalva maneuver
139 non adequate episodes of arrhythmia due to oversensing of diaphragmatic myopotentials
were observed in 33 patients.
•11/33 patients had a total 32 high energy shock occurred. ***The oversensing of
diaphragmatic myopotential to be distinguished from lead failure.

1ST in patients with ICDs 41

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

D. G enerator M alfunction & O ther Problems

A uthor(s)
/year
Groh
et al / 1999

Subjects
(N=total)
N = 169

Research
Design
Post only
design

Kolb
et al /2001

N = 4/341
patients

Retrospective
Study

Anfinsen
et al /2002
Kolb
et al/2002

N= 1

Case study

N= 1

Case study

Chan
et al /2005

N=2

Case study

Finding (s) R/T 1ST # & Cause(s)
• G1: No any negative response in routine exposure (10-15 seconds)
• G2: 3 subjects experienced inappropriate tachyarrhythmia detection,
• G3: 19/126 showed evidence of oversensing.
• no ICD reprogramming was observed in any of the ICDs in all 3 groups.
Case 1, one shock delivered at the time she cleaned the lamp that connect to 230V,
50Hz alternating current.
Case 2, one 1ST when using a vibrator for genital and anal stimulation
Case 3, was treated by electronic muscle stimulation of the gluteal region , EMI lead to
detection of VF and response shock twice.
Case 4, 2 episodes of detectionof VF during sinus rhythm with a normal rate recorded by
device at the time patients was using a percussion drill.
2 ISTs occurred during brain MRI procedure.
a defibrillation shock without warning symptoms at the moment patient touched washing
machine.
-Hemodynamic instability.Ruled out sensing problems, No myopotentials;
-Rule out lead and pulse generator malfunction by the evidence of X-ray and interrogation data
(history). -S/P washing machine was not properly grounded.
Case 1, received one 1ST at the time he operating power drill while it was raining and he wore
a pair cotton gloves.
Case 2 , received one 1ST while He used his wet hand to touch the old washing
machine, which current was leaked.
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F. Interferences with Environm ent

Author(s)
/year
Capoferri
et al /2004

Subjects
(N=Total)
N = 100

Research
Design
Prospective
observation
study

Carnes
et al/2004
Mcbride
et al/2004

N = 1

Case study

N = 1

Case study

Finding (s) R/T 1ST # & Cause(s)
•19 (19%) patients experienced inappropriate therapy.
12/19 received shock.
• Causes of 1ST : Atrial tachycardia : 8; Sinus tachycardia : 9; T wave oversensing : 2.
• No significant difference of the incidence rate of 1ST in primary prevention and secondary
prevention groups.
Venlafaxine, an antidepressant with cardiac sodium channel blocking activity, was identified as
a potential contributor to patient’s elevated defibrillation threshold.
After consuming 2 to 3 doses of Metabolife 356 (a dietary weight loss supplement), patient
received 4 1ST within 3 days. Device interrogation revealed atrial tachycardia.
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G. Interaction w ith Drug

A uthor(s)
/year
Schim pf
et al/ 2003

Glikson
et al/2004

Champagne
et al /2005

Subjects
(N=total)
• N =5 from
two families
• structurally
normal hearts,
• excessively
shortened QT
intervals &
positive
fam ily Hx of
SCD.
• N = 82
• stable VT
• mean age :
66.2 ±11.3,
• stable VT
N =18
idiopathic VF
out o f 445
ICD
recipients

Research
Design
Case
study

Retrospecti
ve
analysis

Prospective
cohort
study

Finding (s) R/T 1ST # & Cause(s)
• 3 o f 5 patients received ISTs for T wave oversensing.
• Schim pf et al concluded that increased the risk for 1ST is inherent due to the
detection of short-coupled and prominent T wave.

• 29 (35%) patients had at least one 1ST.
• Hemodynamically stable VT were at considereable risk for subsequent unstable VT
•No description of the events of 1ST. But Glikson et al suggested that degree of the structure
of heart disease may be as or more important than absence or presence of arrhythmia
symptoms for predicted death.
7/18 patients received a total of 27 shocks.
• 8/18 (44%) subjects received 1ST for a total 21 discharges.
• Causes:
-AF: 12/21 (57%) episodes in 14 patients, these patients are older, mean age 53± 14,
-Sinus tachycardia : 6/21 episodes in 4 patients with a mean age of 31+13 years.
-Lead malfunction : 3/21 episodes in 2 patients.
-Unknown : 6/21, episodes in 2 patients & had experienced 1ST for AF.
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H. Specific Clinical Characteristics

Specific Clinical Characteristics

A uthor(s)
/year
Messali
et al /2004

Subjects
(N=Total)
N= 1

Research
Design
Case study

Steinbrook
/2005

N=1

Case Study

Finding (s) R/T 1ST # & Cause(s)
6 shocks on 03/31/00, SCD on 06/29/00.
Data storage of fatal event showed an episode of ventricular oversening during sinus rhythm
that was designed as VF because of some short cycle lengths < 300ms. This false detection
triggered the first shock and the five subsequent shocks within 2 minutes, the 6th shock induced
a true VF that could not be treated because the end of therapeutic procedure had been reached.
Subject died suddenly, EGM revealed the device had short-circuited internally while
trying to deliver high voltage therapy, it was perm anently disabled. M ore over, its
memory had been destroyed, making the time o f failure im possible to pinpoint.
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CHAPTER III
M ETHODOLOGY
Research Design
This five-year retrospective study was designed to analyze the incidence of
appropriate and inappropriate shock and the clinical predictors for inappropriate
shock in a group o f ICD recipients from a university medical center. This study was
carried out by reviewing ICD interrogation records and medical charts.
A retrospective method was chosen prim arily because the knowledge base
regarding factors that contribute to 1ST is currently at the descriptive level. It is
known that the events contributing to 1ST include multiple intrinsic and extrinsic
factors; however, there are many gaps in current knowledge regarding these clinical
characteristics and their associations to 1ST. A retrospective method examining 5
years o f patient data was used to capture a variety o f salient factors related to the
incidence o f 1ST. However, this investigation may still have been confounded by
the possibility o f two problems: first, that the observed time period was too short to
provide enough information; and second, that rapidly changing technological and
pharmaceutical developments in devices and treatments may have rendered data
difficult to evaluate on a cohort basis. With these possible problems in mind, the
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current study was based on data gathered over a five-year period, a moderate
amount o f time that can provide sound results for analyzing the maximum strengths
and minimal weaknesses o f a cohort.

Research Setting
This study was conducted at the Arrhythmia Clinic at the University of
Medical Center in Southern California, USA. This university medical center serves
the surrounding metropolis and participates as a tertiary, regional, referral center for
the area's cardiovascular patients. Although the majority o f patients were local
residents at the time o f ICD implantation and follow-up, some patients came from
areas outside o f the region. Therefore, this study has the benefit o f being based on
results from a diverse group o f participants. This hospital has well established
systems in its Arrhythmic Clinic. Patients who undergo ICD implantation receive
follow-up care in the clinic, including interrogation procedures to examine the ICD
device function. Interrogation allows electrophysiologists to determine effects from
specific forms o f electrical shock therapy that a patient received since the previous
clinic visit. Lead integrity and battery status are also checked. The ICD device can
then be adjusted to optimize detection and therapy parameters. Most ICDs record
the patient’s electrocardiographic tracing at the time o f arrhythmia detection. This
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the patient’s electrocardiographic tracing at the time of arrhythm ia detection. This
inform ation can then be analyzed at follow-up visits to determine the nature of the
arrhythm ia and the efficacy of the electrical therapy that was given.
The cardiac electrophysiologist, along with a trained technician and/or a
cardiovascular nurse, typically conducts an interrogation once every three months.
An interrogation is also conducted as the device approaches elective replacement,
as well as at any tim e of symptomatic events (e.g., shock occurrence).

Sample
Criteria fo r Sample Inclusion/Exclusion
The target group consisted of ICD recipients who underwent follow-up
examinations in the M edical Center Arrhythmic Clinic from January o f 2000 to
M ay of 2005.
The following inclusion criteria were utilized for this study:
1) Persons age 18 and above who had received an ICD and attended one or
more ICD clinic visits at the medical center;
2) The docum ented occurrence of an appropriate shock (i.e., a shock delivered
in the presence of VT or VF), and/or an inappropriate shock (i.e., a shock
delivered in the absence o f VT or VF).
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2) An incomplete chart record regarding pertinent study data.

Data Collection
Data Collection Instrument
The data collection form was designed by the researcher and reviewed by
two electrophysiologists for content validity (see Appendix D). Each item was
designed to obtain appropriate demographic information and clinical characteristics.
In addition, indications for ICD implantation, clinical history, underlying diseases,
and prescribed medications were recorded. Device information and the history o f
shock events were integrated as well.
Validity and Reliability o f the ICD Records and Charts
Records from medical charts and ICD records offer objective evidence (Eder,
Fullerton, Benroth, & Lindsy, 2005). Descriptions o f events reported by patients
and their families were recorded by an examining physician shortly after the actual
1ST events. Therefore, error variance in research conclusions should be minimized
by the short time interval between the occurrence o f the event and its report.
To minimize the variability and increase the precision o f measurements, all
data were collected by the researcher and confirmed by an electrophysiologist. Thus,
concerns of inter-rater reliability have been minimized.
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concerns o f inter-rater reliability have been minimized.
Data Collection Procedures
Following appropriate IRB approval from the major university medical center
in Southern California that served as the data collection site, the researcher
collected data from the clinical charts of ICD recipients who had attended ICD
clinics from January 1, 2000 to M ay 31, 2005. The researcher exam ined the charts
to confirm that the criteria for study inclusion were met. Once the established
criteria were met, the researcher recorded the data of applicable subjects on the
collection sheet (Appendix E).

Data A nalysis
This study utilized descriptive statistics, correlations, and regression models
to perform the required statistical analyses. Calculations were performed by using
SPSS 13 for W indows (SPSS, Inc., 2005).
For the purposes o f this study, appropriate shock was defined as a shock
developing in the presence of VT or VF, and inappropriate shock therapy (1ST) was
defined as a shock developing in the absence o f VT or VF. For data analysis
purposes, the occurrence o f inappropriate shock therapy was considered as the
dependent variable. Independent variables included sex, age, N YH A Functional
Class, LVEF, structural / nonstructural heart disease, and AF/atrial tachycardia.
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two groups: ages < 65, and ages ^ 65. The convention within medical literature is
to present LVEF by range. Thus, the researcher utilized the three levels of
classification o f LVEF ranges utilized in the literature: normal ^ 50%, moderately
depressed: 35-49%, severely depressed ^ 34 %. Therefore, in this analysis, ordinal
variables (e.g., NYHA functional class, LVEF) and age group were used in chisquare procedures to test the frequencies o f categorical variables related to 1ST.
The following statistical analyses were performed to achieve the specific
aims o f this study. Continuous data, such as age and follow-up months, were
expressed as a mean and standard deviation (M ± SD). Categorical data were
compared utilizing a chi-square test. Predictors o f risk factors were determined by
multivariate logistic regression analysis. The alpha level for this study was
established at 5% (p = .05). Correspondingly, when the probability o f making an
alpha error was equal to or less than 5% (p < 0.05), the result was considered as
statistically significant.
To achieve Specific Aim #1 (to describe the incidence o f appropriate and
inappropriate shock occurring in a group of ICD recipients seen at the specified
university medical facility between January 2000 and M ay 2005 for emergent and
routine follow-up visits), variables were analyzed and the following descriptive
statistics were performed.
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Calculation of the following factors required special attention: the total
number o f appropriate shock occurrence(s) and the total number o f inappropriate
shock occurrence(s); and the percentage o f appropriate shock and inappropriate
shocks per total number o f patients. These rates o f appropriate and inappropriate
ICD shock therapies were determined by dividing the number o f therapies
experienced by the total number o f patients, by the number and percentage o f men
and women experiencing inappropriate shocks.
To achieve Specific Aim #2 (to describe the relative risk between 1ST and
specific factors i.e., age, gender, heart disease severity, structural heart disease, nonstructural heart disease, atrial fibrillation) the following steps were taken:
1) The frequency and proportion o f each clinical risk factor associated with an 1ST
was first calculated.
2) The researcher then analyzed the relationships between each risk factor and the
frequency of ISTs, using chi square testing. Following that, the researcher applied a
logistic regression model to identify the clinical predictor(s).
Post hoc testing was employed to detect significant differences among the
causes o f an 1ST. If no significant differences were detected, the next step was to
use another procedure to further investigate any relationships between the
frequency o f inappropriate shock therapy and certain variables and/or risk factors
by adding a covariate in the event that another variable was confounding the results.
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To achieve Specific Aim #3 (to describe the frequency o f ISTs in a group of
ICD recipients by risk factors (e.g., atrial fibrillation, lead problems, double
counting) and the frequency and proportion o f each risk factor associated with an
1ST, the following procedures were utilized. The number o f ISTs for each risk factor
(i.e., the presence o f atrial fibrillation, lead problems, double counting) was divided
by the number o f 1ST events experienced per patient, and by the total number of
patients over time.
To achieve Specific Aim #4 (to investigate any significant correlations
between relevant clinical factors and the occurrence o f 1ST), an analysis examined
the relative risks between structural heart disease, non-structural heart disease, heart
disease severity and the incidence o f an 1ST. The clinical factors examined included
antiarrhythmic medications taken, device mode, model, and device programming at
the time of the inappropriate shock event.

Human Subjects
This study was a retrospective chart review with limited access to
identifying personal information. Therefore, with the authorization o f an HIPPA
Waiver (i.e., waiver o f consent), in accordance with the HIPPA Privacy Rule, 45
CFR 164, section 512 (I), the need for signed informed consent was waived. IRB
approval was obtained from USD (Appendix E) and from UCSD M edical Center
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( Appendix F) prior to data collection. The direct risks to participants in the study
were minimal and every effort was made to protect confidentiality. Only a code
number was used to identify participants, and no patient identifiers appeared on any
data collection sheet. All data were stored in a locked file cabinet at the
researcher’s residence and only accessible to the researcher. All data were kept for a
minimum of five years before being destroyed. Results were only reported through
unidentifiable or aggregated means.

Risk Management
Only the researcher had access to the anonymous subj ect data throughout
the research process. Prior to analysis, all subjects were assigned a case number.
The protected health information o f each patient was not reused or disclosed for any
purposes other than that o f the study.

Potential Benefits
There were no immediate, specific benefits to any individual subjects.
However, the potential benefits o f this research to the society were significant. An
enhanced understanding o f the predisposing factors related to inappropriate shock
can potentially assist health care professionals in providing more effective patient
education and clinical interventions. In addition, such descriptive research can
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provide a basis for future research that ultimately may enhance the well being of all
ICD patients.

Risk/Benefit Ratio
Thus, from the discussion above, the potential benefits o f this research
outweighed the minimal risks to subjects in this study.
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CHAPTER IV
RESULTS
Subjects and Sample Characteristics
Two hundred and twelve patients were listed on the Electrophysiology laboratory1s
ICD roster. Out o f that group, one minor patient (i.e., under 18 years old) was excluded.
Also excluded were patients who came to the electrophysiology laboratory solely for ICD
device implantations, generator changes, or lead replacement procedures. The researcher
was unable to locate 22 charts and noted key data missing from the records o f another 43
patients. The remaining 119 patients had sufficient data for analysis and review. Figure 3
illustrates the schematic summary o f subject inclusion.
Using the period from January 1, 2000 to M ay 31, 2005, data from 119 patient
records were included in this study; a total o f 2,868 months were analyzed. The mean
follow-up period was 24.1 ± 16.2 months (ranging from 1 to 53 months). Patients with 53
months of follow-up had received ICD implantations at an earlier time than in 2000.
Subject demographic and clinical characteristics are displayed in Table 3 The
researcher’s chart reviews uncovered a variety o f indications for ICD implantation, with
many patients having more than one type o f heart pathology diagnosed. In examining the
patients and their characteristics, the majority o f participants were male (n = 98; 82.4 %);
were NYHA Functional Class II (n = 39; 32.8 %); and had experienced a severe decrease
in LEVF (n = 90; 75.6%). Only three subjects had nonstructural heart disease. With
regard to age, there were slightly more patients in the elderly group (age > 65, n = 67; age
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<65, n = 52), but this difference was not statistically significant (x2 = 1.891, p > .05).

ICD Roster
N=2\2

Excluded
n= 103

- ICD implantation generator
changes, lead change from
research site and referral from
all other hospitals
-N o visit
-A ge <18
- Unable to find the location
- Data missing

Included
N = 119

No Shock
n = 90

Appropriate
Shock
n = 16

Inappropriate
Shock
n = 13

Figure 3 Schematic Summary o f Subject Inclusion
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Table 3
Demographic and Clinical Characteristics o f Subjects
Variable
Sex
Men
Women
Age
Mean (in years)/Range

Outcome (%)
98 (82.4%)
21 (17.6%)
65.4 ± 15 ( 2 9 - 8 9 )
51.0 ± 9.6
76.6 ± 6.4

<65
>65
Implant Indications
SCD

9 (7.6%)

VT/VF
ICM
DCM
HCM
AVRD

29 (24.4%)
42 (35.3%)
35(29.3%)
2(1.7% )
2(1.7% )

Heart Disease
Structural
Non Structural

116
3

NYHA Functional Class
I
II
III
IV

27 (22.7%)
52 (43.7%)
39(1.0% )
1 (0.8%)

LVEF n = 118
50%
35-49%
<35%

10(8.4% )
18(15.1% )
90 (75.6%)

ARVD= Right Ventricular Dysplasia, HCM = Hypertrophy Cardiomyopathy
DCM = Dilated Cardiomyopathy, ICM = Ischemic Cardiomyopathy,
SCD = Sudden Cardiac Death.
VT/VF= Ventricular Tachycardia/ Ventricular Fibrillation
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Data Analysis Related to the Aims o f This Study
Specific Aim #1
Specific aim # 1 o f the study was to describe the incidence o f appropriate and
inappropriate shock occurrence in a group o f ICD recipients, as well as to account for the
incidence of appropriate shocks and inappropriate shocks for patients who visited the
medical facility between January 2000 and M ay 2005 for emergent and routine follow-up
visits.
Descriptive statistical analysis was performed to determine the profiles of shock
occurrence in this study group. In this follow-up period, with a mean time follow-up o f
24 .1± 16.2 months (range o f 1- 53 months), there were 90 subjects who had not
experienced any shock treatment. Sixty shock events occurred for 29 (24.4%) patients; 16
(13.4%) patients received 44 appropriate shocks and 13 (10.9%) patients received 16
inappropriate shocks. Thirteen out o f 119 patients (11 %) experienced 1ST, and 12 out o f
13 1ST subjects were men. Shock profiles are displayed below in Table 4
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Table 4
Shock Profiles
Shock Type

Num ber o f patients
(% )N = 119
90 (75.6)
16(13.4)
9 (7.6)

Number of Shocks

Coexisting Shock

4 (3.4)

-

Appropriate Shock Total

20(17)

No Shock
Appropriate Shock(only)
Inappropriate Shock (only)

1ST total
Male
Female
Shock Total

13(11)
12(10)
1 (-8)
29 (24.4)

0
44
16

60+

See Table 5 for other demographic information concerning the 1ST patients.

Table 5
Inappropriate Shock Therapy Patients Profile
Variables
Gender
Age
NYHA Class
LVEF
Structural HD
Hx o f AF

Outcome (Number o f Patients)
Male (12)
Female (1)
> 6 5 (7)
< 65 (6)
1(4)
11(2)
111(7)
>50% (2)
35- 49 %(1)
<35% (9)
Yes = 13
No = 0
Yes = 10
No = 3

Specific Aim #2
The second specific aim o f this study was to describe four associations: the
relative risk relationships between age group and 1ST; gender and 1ST, heart disease

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1ST in patients with ICDs 61

severity and 1ST; structural/ non-structural heart disease and 1ST; and the history of atrial
fibrillation and 1ST.
To test the relationship between heart disease severity and 1ST, the researcher
examined whether the incidence o f inappropriate shock correlated with ICD recipients’
severity of disease according to left ventricular ejection fraction (LVEF; i.e., very severe
<35%, moderate severe 36-49%, normal > 50%).

Additionally, the NYHA functional

classes (i.e., I, II, III, IV) o f structural heart disease were examined to identify any
significant correlations with the ICD recipients’ non-stmctural heart disease.
Chi-square analysis was chosen to compare the 1ST group to the non-IST group in
terms o f the frequencies o f ordinal variables (i.e., NYHA functional class, LVEF) and
categorical variables (i.e., structural heart disease and non structural heart disease) as
related to an inappropriate shock. These findings are displayed in Table 6
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Table 6
Inappropriate Shock in Chi-Square Com6parisons between 1ST and Non-ISTpatients
(N = 119)
Potential Clinical Predictors
(N)
Sex

Male (98)
Female (21)

Age Group < 65 (52)
> 6 5 (63)
NYHA Class I
II
III
IV
LVEF
> 50 %
35-49 %
< 34 %
Structural HD Yes (115)
No (4)
Atrial Fibrillation Yes (13)
No (10)

1ST

t

Yes
12
1

No
86
20

6
7
4
2
7
0
2
1
9

46
59
22
50
32
1
8
17
80

13
0
10
3

102
4
3
70

...

P

1.242

.537

.809

.667

8.731

.189

1.792

.774

.410

.815

11.993

.002*

d f = 2, *p<.01
To characterize patients who were prone to develop an inappropriate shock, the
researcher did the following: 1) comparison o f clinical variables; 2) analysis o f
characteristics, including demographic information; 3) examination o f subjects’ histories
o f atrial arrhythmia, underlying heart disease, and ejection fraction; and 4) examination
o f the clinical characteristics o f each qualifying arrhythmia. None o f these variables was
predictive of a future development o f 1ST, except atrial tachycardia arrhythmia. To
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account for the difference in the relationship between these potential risk factors,
regression models were used; however, no predictive variables were identified. Details of
the comparison of variables between the 1ST and non-IST groups are summarized in
Table 7.
Table 7
Likelihood Ratio Tests
Model Fitting
Likelihood Ratio Tests
Criteria____________________________________________________

Effect
Intercept

-2 Log
Likeliness of
Reduced Model
37.080

Chi-Square

df

.000

0

P

Age Group

38.487

1.407

2

.495

Gender

38.489

1.409

2

.494

NYHA Class

47.543

10.463

6

.106

LVEF

38.146

1.066

4

.900

Structural

37.187

.107

2

.948

AF /Atachy

51.959

14.879

2

.001*

*p = .001.
As depicted in Table 6, atrial fibrillation was significantly correlated with the
incidence of 1ST i X ~ 11.993, p = .002). However, gender (%2 = 1.242, p = 5.37), age (%2
= .809, p = .667), NYHA (x = 8.731, p = . 189), LVEF (x2 =1.792, p =.774), and structural
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heart disease (%2 = .410, p = .815) were not statistically significant identifiers for 1ST.
These same variables were repeated using a logistic regression analysis, and
results were similar. In this analysis, atrial tachyarrhythmia demonstrated an even higher
significance in the regression analysis (x = 14.879, p = .001) than in the chi square
analysis (p = .002).

Specific Aim #3
This study’s third specific aim was to describe the frequency o f ISTs in a group of
ICD recipients by risk factors (e.g., atrial fibrillation, lead problems, double counting).
Thus, descriptive statistics evaluating the frequency and proportion o f each risk factor
associated with an 1ST were performed.
The number o f ISTs for each independent variable (e.g., atrial fibrillation, double
counting) is reported and divided by the number o f inappropriate shock therapies
experienced per patient and by the total number o f patients over time.
IST’s occurred in eight patients in the presence o f atria arrhythmias (i.e., flutter,
fibrillation) or sinus tachycardia.

In one subject, an 1ST occurred following a missed

dose o f mexiletine. Other concurrent clinical events included double counting and T-wave
over-sensing secondary to an imbalance o f electrolytes. Table 8 displays the incidence o f
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1ST by variable factors.

Table 8
Incidence o f ISTs by Variable Factors

Number of
subjects
Number of
1ST

AF/
A tachy
8

ST
/NSR
2

Double
counting
2

Lead
problem
1

Drug
Interaction
1

Total

10

2

2

1

1

16

13

NSR= normal sinus rhythm, ST = sinus tachycardia
Specific Aim #4
The study’s fourth specific aim was to investigate significant correlations between
clinical information and an 1ST, and, taken in combination, to reveal any clinical
predictability for the incidence o f an 1ST. Variables analyzed include demographic
characteristics, histories o f previous underlying heart disease, ejection fraction, and
medications taken at the time o f the 1ST.
Medical charts and ICD follow-up records were reviewed for the clinical
characteristics o f the presenting arrhythmia. All information regarding episodes of stored
arrhythmias were recorded at the discretion o f the physician treating the individual
patient. The elements recorded in the subject record as possible predisposing factors
triggering ISTs are discussed below.
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Most patients at risk for an 1ST had severe chronic heart disease and multiple
independent risk factors for atrial fibrillation. More than 70% o f the ICD patients had
significant coronary artery disease, and most had severe left ventricular dysfunction with
an ejection fraction o f less than 30%. A minority o f ICD patients (n = 3) had normal
coronary arteries and electrically compromised, right ventricular dysplasia, mitral valve
prolapse, or hypertrophic cardiomyopathy (HCM). M ost ICD patients were also at risk
for potential triggers o f inappropriate shock known to precipitate atrial fibrillation and
lead to SCD if left unchecked. These triggers included hyperthyroidism, diabetes mellitus,
and valvular heart disease.
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Characteristics o f Subjects and Incidence o f Inappropriate Shock Therapy
p
t
#

Age
Sex

1

82
M

VT CHF

68
M
48
M

VT ICM

85
M
87
M

VT
DCM

2
3

4
5

Implant
Indica-tion

DCM

History
of
HD
Chr AF CABG
Syncope
H ypothyroidism

N
Y
H
A
II

E
F

Cause o f 1ST
Event

35

M ode

AA Drug
at time of
Event

Fup
(M)

VVIR

M etoprolol
Lanoxin

49

Up grade to
dual cham ber
ICD

DDD

Coreg Digoxin
Am idarone
Coreg Laoxin

25

M onitor VT

18

Reposition
lead

One shock due to AF
Charge time 6.55 sec.

I

58

III

10

M VP

I

N/A

Discharge for AF

VVI

Coreg Digoxin

53

PAF

III

15

Double counting

Biv
DDD

Digoxin

10

NSVT
PAF
NIDCM
HTN ESRD

M issing one dose of
M exiletine
Lead dislodge

Intervention

Biv
DDD

Expired
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Table 9

Ag
e
Sex

6

44
M

DCM

CHF
MI
LBBB

7

48
M

HCM

8

71
M

9

74
M

Im plant
Indication

History
of
HD

N
Y
H
A
III

24

Sinus tachycardia as VT

Biv
DDD

A FR V R

II

34

One shock for AF

DDDR

I

18

One shock
for atrial flutter

DDDR

M exiletine
Sotalol Lanoxin

22

DCM

CHF
AF

Arrange D FT
testing

VT

ICM

I

35

Shock for SVT and AF
RVR
Dehydration, Creatine f
K +t

DDDR

Sotalol
Laoxin
Amidarone
Coreg

41

Coreg increase
to 625 mg. DFT
rem ained stable
on am idarone
w/no
antiarrthm ic
event.

E
F

Cause of 1ST Shock
Event

Mode

A A Drug at time
of Event

Coreg Digoxin

FUp
(M)
7

Intervention

VT zone
increased, VT
onset, stab
discrim ination
ON

46
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Pt
#

Ag
e
Sex

N
Y
H
A
III

E
F

Cause of 1ST Shock
Event

Mode

10

49
M

VT

TOF VHD

30

One shock for A Tachy
secondary induced by
exercise

DDDR

11

79
F

AVRD

NSVT SM VT
PAF

I

72

Two shocks for sinus
tachycardia

12

54
M

ICM
N IDCM

Chr. AF

II

30

13

48
M

NICM

C h rA F

III

22

Implant
Indication

History
of
HD

AF = atrial fibrillation
PAF = paroxysm al Atrial fibrillation
TO F = Tetralogy o f Fallot

FUp
(M)

Intervention

Coreg

10

Biv
DDD

Cozaar
Amiodarine
Norvasc

53

One shock due to double
counting

Biv
DDD

Coreg
Digoxin

18

4 shocks - 3 for VT VF
1 for AF RVR while
performing stress test

Biv
DDD

Coreg , Cozaar
Digoxin

22

Since ICD firing
in VT zone
during exercise
induced ST.
After VT turned
off. VT
Ablation
No evidence for
reversible
perfusion to
suggest
inducible
coronary
insufficiency
Rate increase to
175, VT interval
decrease to 343
ms
ICD normal
function
Recom m end
rate control

A A Drug at time
of Event
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Description o f 131ST Patients
As presented in Table 9, in the 1ST group, all patients had structural heart disease.
Twelve patients were men. Subjects aged 65 years and older were slightly more
numerous than younger patients (7 vs. 6), but this difference was not statistically
significant. Eleven out o f 13 patients had LVEFs that were severely depressed (i.e., below
35%), but there were no patients experiencing 1ST that had moderately depressed LVEFs.
Two patients had a normal LVEF: 1) a patient with an LVEF o f 58% who had CAD
NSVT; 2) another patient with an LVEF o f 72% who had poor right ventricular function
due to right ventricular dysplasia.
The m ajor causative factor o f 1ST in this group was atrial fibrillation (n = 8). Two
patients had sinus tachycardia. Double counting occurred in two patients, one patient’s
1ST was associated with lead dislodgement, and another patient’s 1ST was caused by
missing one dose o f Mexiletine. This type o f event has been posited to be associated
with an increased defibrillation threshold (DFT) (Murakawa, Yamshita, Kanese, Omota,
1998; Rajawat, Patel, Gerstenfeld, Nayak, and M archinski, 2004).
Regardless o f a variety o f indications and disease diagnoses (including two
patients with congenital heart disease), 10 out o f 13 subjects who experienced 1ST had
coexisting chronic AF or paroxysmal atrial fibrillation (PAF). Finally, three patients had
no history o f chronic AF; however, they all had at least one inherited risk factor for
developing AF.
Another finding from this group was the importance o f occurrences o f trigger
events. In two patients (Patient 1 and Patient 4) the ICD device was suspected to lack the
ability to discriminate between SVT and VT, and, after changing W I mode to DDD,
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there was no further 1ST. However, 1ST occurred in the remaining patients who were
implanted with a dual chamber device (Patient 5) and a biventricular device (Patient 6
and Patient 8). According to chart records, a missed Mexiletine dose was suspected to be
the trigger o f the 1ST secondary to alternating defibrillation threshold for Patient 2.
Two subjects receiving ISTs had similar situations. Patient 10, who had atrial
tachycardia, received an 1ST while he was performing extreme exercise, and Patient 13
received an 1ST while he was undergoing a stress test. The patient activity at the time o f
the lead dislodgement case (Patient 3) was not recorded. However, all of these three
patients were males and in their 40s.

Summary
The major finding o f this study was a significant correlation between the occurrence o f
atrial fibrillation and the incidence o f 1ST. The trigger events precipitating 1ST were
varied in this study population, and their salience as clinical predictors o f 1ST are
discussed in the next chapter.
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Figure 3
Patient 10 received an 1ST while he was performing extreme exercise.
An inappropriate shock from atrial fibrillation with rapid ventricular response.

1
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Figure 4
Patient 13 received an 1ST while he was undergoing a stress test.
Inappropriate shock from a sinus tachycardia that had a ventricular rate fast enough to be
detected in the VT zone o f the device
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CHAPTER V
DISCUSSION
Overview
This investigation is an updated cohort study o f inappropriate shock therapy. The
study represents the first research findings from a nursing perspective on the
physiological aspects o f 1ST in ICD recipients. Unlike previous cohort studies that only
present the rates o f causes o f 1ST, including the most recent such study by Thenus et al.
(2005), this study explores underlying trigger events by incorporating these events at the
time when 1ST occurred, as well as by correlating subjects’ clinical histories.
The actual data collection period o f Thenus et al.’s (2005) study is not indicated;
but the observation period o f this present study was specifically conducted at a teaching
hospital as well as a tertiary referral hospital in Southern California from July 2000 to
May 2005, with a mean follow-up period o f 24.1 ± 16.2 months.
Overall, this study reveals that, in 13 (9%) out of 119 patients who received
inappropriate shock, AF remained the major cause o f 1ST. In addition, 12 out o f 13
patients receiving ISTs were men. The researcher posits that ISTs m ay be related to m en’s
increased risk for atrial fibrillation. However, given that 98 out 119 patients (82.4%)
were men, this conclusion is based on a small sample size that failed to achieve statistical
significance and m ust be viewed with caution (%2 = 0.995, p > .05).
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Incidence Rates
In previous cohort studies, incidence rates o f 22% (Grimm et al., 1993) and 14%
(Rinaddi et al., 2004: Thenus et al., 2005) were documented, and inappropriate ICD
therapy was attributed to atrial tachyarrhythmias. However, it is unknown what
percentage o f total events atrial tachyarrhythmias constituted in Thenus et al.’s study.
The incidence o f ISTs in this present study was 11%. This lower incidence might be due
to the following reasons: (a) continuous refinement in the ICD devices; (b) rigorous
procedures for performing a follow-up visit. The incidence rate also may have been
underestimated because o f patients lost to follow-up (e.g., moving, traveling, inability to
locate patient or chart). However, those events also occur in most retrospective cohort
studies.
A ge and Gender
As in previous studies (Grimm et al.1993; Nanthakumar, 2003; Rinaddi, 2004;
Thenus et al., 2005), the present study did not show any significant difference in age and
gender between the 1ST group and the non-IST group. Even though 12 out o f the 13 1ST
subjects were men, the large proportion o f men receiving this form o f treatment was not
significantly different between the groups (p = .537).
Atrial Fibrillation
Previous studies have investigated whether clinical variables could predict the
delivery o f 1ST in ICD recipients. Rinaddi et al. (2004) and N anthakum ar et al. (2003)
observed previous histories o f AF at the time o f implantation to predict the incidence o f
inappropriate shock for patients with single chamber ICDs. Since the first cohort study
(Grimm et al., 1993), and despite the advent o f DDD, AF still remains the major cause o f
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1ST (Thenus et al., 2005).
NYHA Functional Class
Nanthakum ar et al. (2003) also noted that NYHA Class I could predict 1ST. In
this study, however, the subjects’ statuses o f function classes fluctuated and could not
reflect the level o f severity for heart disease. Therefore, it was not surprising that
identification o f significance was not achieved at the level o f NYHA Functional Class.
Ejection Fraction
As in the work o f Thenus et al. (2005) and the present study did not found any
significant differences in this factor related to the development o f 1ST. One explanation
could be that, although the value of LVEF is more objective (e.g., measured by rest
technetium-99m-methoxy-isobutyl-isonitril (MIBI), echocardiography, or by the
guideline o f indications in Gate Bayesian Reconstruction In Emission Tomography
[SPECT]), most patients were amalgamated into the severely depressed LVEF category
in order to receive ICD therapy.
Eleven out o f 13 patients with at least one 1ST experience had severely depressed
LVEFs. However, other subjects with severely depressed LVEF had experienced no 1ST
event. Therefore, the data could not support this variable as a clinical predictor.
Structural H eart Disease
A previous study (Rinaddi et al., 2004) posited that, while DCM patients
comprised 50% o f the study participants, a higher incidence o f 1ST (80%) occurred in
these patients. Rinaddi et al. concluded that patients with DCM were more likely to be at
increased risk for ISTs. In this study with expanded indications, a variety o f diagnoses are
shown to have been occurring in ICD recipients. Because most patients had multiple
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forms o f heart diseases as well as other disease processes, DCM could not be considered
as an independent variable, or as a clinical predictor. However, after grouping heart
disease into structural and non-structural categories, the results demonstrated that almost
all ICD recipients had structural heart disease (n = 116). Therefore, the number of
patients with non-structural heart disease (n = 3) was too small to utilize structural heart
disease as a grouping variable to test for statistical significance.
Lead Problems
Lead problems are the second major cause o f ISTs, as reported in many articles
(Dorwarth, et al, 2003; Goyal, et al, 2004; Picket et al, 2004). In the present study, only
one patient had an 1ST related to lead dislodgement. While another patient did have a
lead fracture; however the lead was replaced in a timely fashion by rigorous integration,
which contributed to be the lowered occurrence rate 1ST, as the researcher noted in the
ICD record.
Double Counting
In this study, 1ST caused by double counting occurred in two cases in an early
observation with the first generation o f BiV ICD. Although dedicated BiV ICDs are now
available with tachycardia detection only occurring through a single (RV) channel,
continued follow-up o f the many patients who received first-generation devices is needed.
D rug Interaction
In the present study, a unique finding not found in previous cohort studies was
that an 1ST can be caused by missing one dose o f M exitil (i.e., mexiletine). In this patient,
population, mexiletine function in a fashion sim ilar to lidocaine to reduce the
development o f ventricular tachycardia, as has been used in hybrid therapy o f ICD
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recipients (Rajawat, Patel, Gerstenfeld, Nayak, & Marchinski, 2004). However, animal
studies had reported that treatment with mexiletine increases the defibrillation threshold.
Thus, suddenly missing one dose led to altering the serum level o f mexiletine, which then
lead to an 1ST (Bride et al, 1997). As a result, the association o f missing one does o f
M exitil and 1ST, is suspected.
Electrolyte Imbalance
Another 1ST event occurred when a patient was hospitalization for VT/VF.
Predisposed dehydration increased the serum level o f creatine and potassium, as the
interrogation revealed VT and AF with rapid ventricular response.

Events Occurring at the Time o f Inappropriate Shock Therapy Episodes
In this study, eight patients’ 1ST were found to be AF/atrial tachycardia or SVT. In
one case, there was no recorded trigger event; and in another case, the patient’s single
chamber ICD was replaced by a dual cham ber ICD to solve the problem. Another patient
was asked to increase the dosage o f antiarrhythmics. Yet another patient was asked to
take anti-thyroid. Adjustment o f the defibrillation threshold and ablation were performed
for two different patients to solve the 1ST problem. For the remaining two patients in the
1ST group, one 1ST occurred at the time when the patient was undergoing a testing
procedure, the other 1ST occurred at the time when the patient was performing extreme
exercise. Therefore, the clinical characteristics o f patients prone to 1ST should be
incorporated into intervention plans.
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Clinical Implications
Because ICDs are a lifesaving device, the unexpected failure o f one can be
catastrophic. Thus, the findings from this study may have clinical implications that relate
to the safety o f ICD recipients. The following are this researcher’s suggestions:
1. Early identification o f the etiology o f unnecessary shocks to allow for the
immediate institution o f therapy to reduce the risk for subsequent events;
2. Careful monitoring o f concomitant anti-arrhythmic drug (AAD) therapy in
patients with ICD;
3. Reinforcement o f the need for careful electrode lead and generator placement to
reduce 1ST events;
4. Increased awareness that certain testing procedures (e.g., stress tests) may
predispose the patient to 1ST;
5. Development of an updated and effective education program for nurses caring for
ICD patients that incorporates current research findings regarding assessment for
risk factors for 1ST and patient/family education regarding these factors.
Ultimately, the goal is to ensure that ICD recipients achieve optimal care and
recovery status.

Limitations
This study has several limitations. One major limitation is that it is based on a
retrospective design. Data were collected through chart reviews and ICD records. Some
o f the information that the researcher needed was difficult to obtain. For example, if a
patient expired at another hospital, the cause o f death was unknow n and the researcher
could not know if any relationship existed between the cause o f death and ICD device.
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Other patient records may have been lost or were taken elsewhere (e.g., a patient might
move out o f the area). In addition, without the ability to contact patients, the researcher
was unable to know where missing charts were located or about the existence o f charts in
other facilities.
This preset study data did not address the role o f the programm ing in the genesis
o f 1ST as different programming modalities can influence the effectiveness o f shock
therapy. In addition, the researcher was not able to record all medications taken by the
ICD recipients, and medications can alter ICD therapy. Further, the researcher was unable
to obtain all ICD records for review, especially in the event o f an 1ST occurring outside o f
the study site. For these reasons, the researcher may not be in a position to clearly assess
the effects o f risk factors and can only note inappropriate therapy prevalence based on the
ICD records.
The m ajor limitation o f this study is its related small number o f subjects limited
to a single-center ICD clinic registry. As such, the conclusions could be buttressed by
using larger multi-center registries or prospective data from future ICD research.
Especially important would be focusing on data issues and avoid any potential bias
resulting from incomplete data. At the outset, this researcher considered 1ST as the most
clinically relevant event. Inappropriate anti-tachycardia therapy (ATP) that resulted in no
shock or appropriate shock therapy was not assessed. Reasons for not including ATP were
primarily due to missing data secondary to the IC D ’s memory limitations, incomplete
interrogation, or cleared memory. Inclusion o f any o f these data could provide a fuller
understanding o f 1ST phenomenon.
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Suggestion for Future Research
Despite the technological evolution o f ICD devices, AF/atrial
tachycardarrhythmia remains the major cause o f 1ST. Efforts in future research should
include investigations into the events arising from AF/atrial tachycardarrhythmia and
clinical histories that could predispose patients to AF/atrial tachycardarrhythmia. Thus,
the responses o f ICD patients to triggered heart-rate exercise should be carefully studied.
Since antiarhythmics have become an integral part o f hybrid therapy, the alteration o f the
defibrillation threshold by these medications also should be a focus o f future research. As
an 1ST can be triggered by an electrolyte imbalance, there is a need to investigate the
pathways by which an imbalance in specific electrolytes (e.g., potassium) are promoting
the occurrence o f 1ST. Because o f the serious consequences o f device malfunction (e.g.,
sudden death), providing a patient alert system, surveying the reasons for patients missing
a follow-up appointment, and developing a the strategy to assist ICD recipients to
continue regular follow - up should be encouraged. The early detection o f device
malfunction and immediate replacement could avert a tragedy from occurring.
In addition, little is known regarding undersensing as a contributing factor to 1ST ,
and future research should focus on this area. Although inappropriate antitachycardia
pacing may not be as serious as an 1ST, the wrong detection information can significantly
alter hemodynamic functioning. Future research studies that explore more fully all
inappropriate discharges may be made possible as increased m em ory electrogram storage
in the ICD expands.
Despite expanded indications for the use o f the ICD, the percentage o f women
receiving ICD therapy has not increased. This continuing persistent gender differential in
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ICD therapy may need to be investigated using qualitative and quantitative methods, as a
com plex set o f physiological and contextual factors may be operant.
This study represents an initial step in the growing body o f knowledge regarding
an expanding patient population. In the future, a m ultisite expanded longitudinal study
will be necessary to confirm the results seen in this study and m ore clearly elucidate the
multi-factorial nature o f inappropriate shock therapy.
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Trails o f IC D Therapy f o r the Secondary P revention o f SC D
Table 1
Trails o f ICD Therapy fo r the Secondary Prevention o f SCD
Study /Study Period
Population Characteristics,
End Point (s)
Key Finding(s)
N= total
AVID/1993-1997
• N=1016
•Total mortality
•The ICD group experienced a 39%
-Survival of VF,
•M ode of death
reduction death in the first year w ith a
A ntiarhythm ics vs.
-SM VT with near syncope,
•Quality of life
27% and 31% reduction in years two
Im plantable
-SM VT with EF < 40% &
•Cost benefit
and three.
D efibrillator
symptoms.
• Enrollm ent was discontinued
•ICD therapy vs Antiarrhythmic
prem aturely because of a significant
(Amiodarone, Sotalol) therapy
im provem ent overall survival w ith ICD.
CID S/ 1990-1998
• N=659
•Primary end point:
A relative reduction occurred in all
•Resuscitated after out-of hospital
cause m ortality of 19.7% in ICD group.
All causes mortality
Canadian Im plantable
cardiac arrest
•Secondary end point:
A 33% reduction occurred in
D efibrillator Study
-documented VF
arrhythmia death
amiodarone group(this reduction did not
-SM VT with syncope
reach statistical significance).
-SM VT with EF<35%
•Result supports ICD is better than
•ICD (n=328) vs
Amiodarone in the treatm ent o f patients
am iodarone (n=331)
with M SVT or resuscitated cardiac
arrest.
C A S H /1987-1998
•N = 288
•Primary endpoint:
Prelim inary results showed that
• Resuscitated after cardiac arrest
propafenone treatm ent is less effective
Total mortality
Cadiac A rrest Study
secondary to docum ented
than ICD treatment. Therefore, this arm
•Secondary endpoints:
H am burg
ventricular arrhythm ia
was suspended. The ICD group
Recurrences of cardiac
experienced a 24% relative reduction in
•ICD (n=99) vs
arrest requiring CPR
am iodarone (n=92), metoprolol
*Recurrences o f unstable • m ortality with am iodarone /m etoprolol
(p=0.081), non significant.
(n=97), & propafenone (n=58,
Angina
propafenone discontinued 3/92)
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Trail / Study
period
CA BG Patch
/1 990-1997
Coronary Artery
Bypass Graft
patch trail

M A D IT I
1990-1996
M ulticenter
A utom atic
D efibrillator
Im plantation
Trail

Study Population
N=Total
• N= 900, age < 80
• EF <36% &
•Abnorm alities on average signal ECG
- Random ly assigned in
OR after CABG
• CABG+ ICD, n=446
CABG alone, n=454
•N= 196, age 25-80
•Prior MI,
-NYHAclass I-III
-CHF, LVEF<35%
-NVST, VT 3 to30
beats; -Inducible and
non suppressible VT/
VF on EPS, not
suppressed by IV
procainamide)
•101 drug therapy (80
on Am iodarone)
-9 5 ICD

Study Group

Endpoint(s)

Key Finding(s)

ICD vs
conventional
medical therapy

Total
mortality

•The trail was prem aturely term inated because
mortality was equal in the CA BG plus ICD(101
deaths) compare CABG alone 95 deaths;
dem onstrated no benefit of the prophylactic
insertion o f an ICD in patients with an ischem ic
burden and a depression EF undergoing
appropriated coronary revascularization.

ICD vs
conventional
therapy
(Antiarrhythmia
Drugs)

Total
mortality
Cost effectiveness

•39 (39% ) deaths in antiarrhythm ic group vs
15 (21%) ICD group
Hazard ratio, 0.46; Cl, 026-0.82; p = 0.009)
Significant reduction in death from all causes in
ICD group
•ICD cost effective
1ST in Patients with ICDs
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Table 2
Summary>o f ICD Trails fo r the Prim ary Prevention o f SCD
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M USTT
/1990-1998
M ulticenter
U nstained
D efibrillator
Im plantation
M A D IT II /
1998 - 2002
M ulticenter
A utom atic
Defibrillator
Im plantation Trail

Study Population
N= Total
•N=704
•M ore than lw eek post
MI,
-NYHA class I, II, III
- EF<0.40
- Inducible VT on EPS.
- NSVT >3 beats,
•N=1232
• Inclusion criteria :
-W ith M I > 1 month
-EF<35%,
-NYHA class I, II, or
III
•Exclusion criteria :
-CABG or non CABG
revascularization<
3months prior to
enrollment
•ICD (n=742),
•Drug Therapy (n=
490).

Key Finding(s)

Study Groups

Endpoint(s)

EP guided
antiarrhythmic
or ICD therapy)
vs
No
antiarrhythmic
therapy
ICD vs
Conventional
medical therapy

Cardiac arrest
or death from
arrhythmia

•Significant reduction in rate o f cardiac
arrest or death from arrhythm ia with EP
guided therapy; nearly all benefit
attributable to ICD implantation

Total
M ortality

•M ortality Conventional M edical therapy (n= 97,19.8
%)
ICD group (n= 105, 14.2%)
•Hazard ratio 0.69 (95% Cl, 0.51-0.93).
ICD decreased mortality by 34%
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Trail / Study Period
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D efibrillator
in N onischem ic
C ardiom yopathy
Treatm ent
Evaluation

COM PANION
(01/2000-11/2002)
Com parison of
M edical Therapy,
Pacing and
D efibrillation in
H eart Failure

Study Population
Study Groups
N= total
N = 458
ICD vs
•Symptomic CHF+
conventional
nonischem ic
medical therapy
cardiom yophy
(Drug Therapy
[EF<35%]
only)
>10 PVCs/hr or NSVT
•Optimal medical
therapy, n =229.
• Optimal therapy +
ICD therapy, n=229.
1520 patients
Three patient
Heart failure patients
groups
(NYHA class III-IV)
(randomized
w ith EF < 35%, QRS >
1:2:2)
120 ms, PR interval >
1. Optimal
150 ms
Pharmacologic
Therapy (OPT)
2. OPT + CRT-P
3. OPT + CRT-D

Endpoint(s)

Key Finding(s)

•The Primary
End Point:
Total
mortality
•The
Secondary
end p o in t:
All kinds of
death

• Death from any cause; in
-ICD group(n=28),
-Conventional m edical therapy (n= 40)
•Sudden death from arrhythm ia in
-ICD group (n=3),
-Conventional medical therapy (n= 14)
*Significant reduction in overall m ortality
in ICD group.
ICD decreased m ortality by 34%

•Combination
of all-cause
mortality or
first
hospitalizatio
n * as
measured by
time to first
event

• A pacem aker with CRT capabilities (CRTP), in com bination with OPT, reduced the
risk of all-cause mortality or first
hospitalization* by 19% when com pared
with OPT alone.
• A defibrillator with CRT capabilities
(CRT-D), in com bination with OPT,
reduced the risk of all-cause m ortality or
first hospitalization* by 20% when
compared with OPT alone.
• CRT-D, in com bination with OPT,
reduced the risk o f all-cause m ortality by
36% when com pared with OPT alone
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Trail / Study
Period
D EFIN ITE/
2000-2003

The Sudden
Cardiac Death
H eart Failure Trail

Study Population
N= total
N =2521
NYHA II-III, CHF,
EF<35%
ICD and conventional
therapy(n= 829),
Amioderone and
conventional therapy
(n= 845).
Placebo and
conventional therapy
(n=847)

Study Groups
ICD and
conventional
therapy (n=
829) vs
Amioderone &
conventional
therapy (n=845)
vs Placebo &
conventional
therapy(n=847)

Endpoint(s)
Total
M ortality

Key Finding(s)
•Amiodarone has no favorable effect on
survival, single lead.
•Shock only ICD therapy reduces overall
mortality by 23 %.
Conclusions: NIDCM treated with ACE
inhibitors and beta-blockers, the
implantation o f a cardioverter-defibrillator
significantly reduced the risk o f SCD from
arrhythm ia and was associated with no
significant reduction in the risk o f death
from any cause.

Abbreviations:
CAD = coronary artery disease; CHF= congestive heart failure;
EPS = electrocardiphysiology Study; ICD = Implantable Cardioverter- Defibrillator;
EF (LVEF) = left ventricular ejection fraction; NYHA = New York Heart Association Functional Class;
N ID CM = nonischem ic dilated cardiomyopathy;
N SV T = non sustained ventricular tachycardia; PVC= premature ventricular contraction;
SM V T= sustained m onom orphagic ventricular tachycardia; VT= ventricular tachycardia.
CRT- P = cardiac resynchronization therapy - pacemaker
CRT-D = cardiac resynchronization therapy - defibrillation
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Trail / Study
Period
SCD - H eFT/
1997-2003

100

1ST in Patients with ICDs 101

Appendix B
2002 Indications fo r Implantable Cardioverter - Defibrillator Therapy
_____________________ (ACC/AHA/NASPE) Practice Guidelines______________________
Class I: Conditions for which there is evidence and/or general agreement that a given
procedure or treatment is beneficial, useful, and effective.
Class II: Conditions for which there is conflicting evidence and/or a divergence of
opinion about the usefulness/efficacy o f a procedure or treatment.
Class Ha: Weight o f evidence/opinion is in favor o f usefulness/efficacy.
Class lib: Usefulness/efficacy is less well established by evidence/opinion.
Class III: Conditions for which there is evidence and/or general agreement that a
procedure/treatment is not useful / effective and in some cases may be harmful.
Class I indications per level of A, B or C
A. Data were derived from multiple randomized clinical trails involving a large
number o f subjects.
B. Data were derived from a limited number o f trails involving comparatively small
of patients from well designed data analysis data analysis o f nonrandomized
studies or observational data registries.
C. Consensus o f expert opinions was the prim ary source or recommendation.
Class III indications are patients in whom ICD therapy is no appropriate.
CAD, coronary artery disease; EP. electrophysiology
Class I
1. Cardiac arrest due to VF or VT not due to a transient or reversible cause. (Level A)
2. Spontaneous sustained VT in association with structural heart disease. (Level B)
3. Syncope o f undetermined origin with clinically relevant, hemodynamically significant
sustained VT or VF induced at electrophysiologic study when drug therapy is
ineffective, not tolerated, or not preferred. (Level B)
4. Nonsustained VT in patients with coronary disease, prior MI, LV dysfunction, and
inducible VF or sustained VT at electrophysiologic study that is not suppressible by a
Class I antiarrhythmic drug. (Level A)
5. Spontaneous sustained VT in patients without structural heart disease not amenable to
other treatments. (Level C)
Class Ha
Patients with left ventricular ejection fraction o f less than or equal to 30% at least 1
month post myocardial infarction and 3 months post coronary artery revascularization
surgery. (Level B)
Class lib
1. Cardiac arrest presumed to be due to VF when electrophysiologic
testing is precluded by other medical conditions. (Level C)
2. Severe symptoms (e.g., syncope) attributable to ventricular tachyarrhythmias in
patients awaiting cardiac transplantation. (Level C)
3. Familial or inherited conditions with a high risk for life-threatening ventricular
tachyarrhythmias such as long-QT syndrome or hypertrophic cardiomyopathy. (Level
B)______________________________________________________________________________
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4. Nonsustained VT with coronary artery disease, prior MI, LV dysfunction, and
inducible sustained VT or VF at electrophysiologic study. (Level B)
5. Recurrent syncope o f undetermined origin in the presence o f ventricular dysfunction
and inducible ventricular arrhythmias at electrophysiologic study when other causes
o f syncope have been excluded. (Level C)
6. Syncope o f unexplained origin or family history o f unexplained sudden cardiac death
in association with typical or atypical right bundle-branch block and ST segment
elevations (Brugada syndrome). (Level C)
Class III
1. Syncope o f undetermined cause in a patient without inducible ventricular
tachyarrhythmias and without structural heart disease. (Level C)
2. Incessant VT or VF. (Level C)
3. VF or VT resulting from arrhythmias amenable to surgical or catheter ablation; for
example, atrial arrhythmias associated with the Wolff-Parkinson- White syndrome,
right ventricular outflow tract VT, idiopathic left ventricular tachycardia, or fascicular
VT. (Level C)
4. Ventricular tachyarrhythmias due to a transient or reversible disorder (e.g., AMI,
electrolyte imbalance, drugs, or trauma) when correction o f the disorder is considered
feasible and likely to substantially reduce the risk o f recurrent arrhythmia. (Level B)
5. Significant psychiatric illnesses that may be aggravated by device implantation or may
preclude systematic follow-up. (Level C)
6. Terminal illnesses with projected life expectancy less than 6 months. (Level C)
7. Patients with coronary artery disease with LV dysfunction and prolonged QRS duration
in the absence o f spontaneous or inducible sustained or nonsustained VT who are
undergoing coronary bypass surgery. (Level B)
8. NYHA Class IV drug-refractory congestive heart failure in patients who are not
candidates for cardiac transplantation. (Level C)__________________________________
From “ACC/AHA/NASPE 2002 guideline update for implantation o f cardiac pacemakers and
antiarrhythmia devices: Summary article,” by G., J. Gregoratos, J. Abrams, A .E. E pstein,, 2002,
C i r c u l a t i o n , 1 0 6 , pp. 2145-2161.
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Nursing Research Related to Care o f ICD Recipients
(Studies are presented in Chronological Order)
Author/Year

Purpose

Study Design

Fridlund
et al
/2000

Patients with ICDs and
their conceptions o f their
life situations

A 12-month descriptive
longitudinal study was
carried out during a
period of 48 months,
fibrillator Questionnaire

Cowan
et al
/2001

To evaluate the effects of
biofeedback training used
in cardiovascular health
education

Experimental study on

N= 133

bio-feedback training
used in cardiovascular
health education
Follow-up = 2 years

Experimental group
(n=67)

Descriptive longitudinal
study

N= 56
Consecutive ICD
recipients

Flem m e
et al
/2001

To describe changes in
the life situation of
patients with an ICD over
a period of 1 year

Subjects
N= total
N = 46
ICD recipients

M ajor Findings/Suggestions R/T
Education
Overall uncertainty showed a
decrease over time. A statistically
significant difference was found
within the domain “uncertainty”
related to inform ation, suggesting
the need for more education in
teaching skills for health care
personnel.
Psychosocial therapy significantly
reduced risk o f cardiovascular
death in SCD survivals.

Usual care (n=66)
Regarding their overall life
situations, patients expressed
increased satisfaction as well as
less uncertainty and fear. The
research indicates that patients
need more inform ation about
typical changes in patients’ life
situations after ICD im plantation.
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Albarran
et al.
/2004

Purpose

Study Design

To describe how well the
ICD recipients cope with
their situations when they
have the support of a
nurse, and
contrast this data with
that from a control group
receiving conventional
inform ation given by
physicians.

Experimental study
questionnaire, interviews,
and observations.

To explore the nature of
patients’ partners’
experiences from the preICD im plantation phase
up until a m axim um of
20 months at home.

Qualitative study
based on a semi-structured
schedule

Subjects
N= Total
N=20
Experimental groupSupport by nurse
(n=10).
Control groupReceived
conventional patient
education by a
physician (n = 10).
Eight partners
cohabiting with a
recipient o f an ICD

M ajor Findings/Suggestions R/T
Education
Sleep disturbances were the
greatest problem in both the
study group and the control
group before ICD im plantation.
The control group showed need
for more inform ation regarding
the function o f the ICD device.
By means o f a questionnaire,
interviews and observations, the
study revealed great need for
inform ation, and therefore that
planning ways to create this
kind o f education is im portant.
Four themes representing 11
categories conceptualized the
partners' experiences, including:
Acknow ledging the patient's
need for the device, reactions to
the device, Feeling grateful,
W aiting for the shock, K nowing
what to do to safeguard the
patient, and Returning to
normality.
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

A uthor
/Year
Carlsson
et al
/2002

104

D ougherty
et al
/2004a

Purpose
1) To describe the
domains of concerns of
intim ate partners of
sudden cardiac death
(SCD) during the first
year after ICD
im plantation;

Study Design
Secondary analysis of
interview data collected
for the prim ary study
entitled, “Family
Experiences following
Sudden Cardiac
Arrest”

Subjects
N=Total
N = 15
families who met the
inclusion criteria
(sudden cardiac
death survival)

2) To outline the strategies
used by partners of SCD
survivors in dealing with
the concerns and demands
of recovery during the
first year after ICD
implantation.

D ougherty
et al
/2004b

To evaluate the effects of
a short-term intervention
for the initial ICD
recipients

Experimental.
A structured telephone
intervention delivered
during the first 8 weeks
after ICD therapy by
expert cardiovascular
nurses

N = 168
Individuals who had
experienced a first
SCA or lifethreatening
ventricular
arrhythmia requiring
ICD implantation

M ajor Findings/Suggestions
R/T Education
Eight dom ains o f concerns :
I) Care to ensure survival; 2)
The p a rtn e r’s self-care; 3) The
relationship; 4) The ICD;
5) M oney matters; 6) The
future; 7) Health care providers
and family,
or, education & support sources;
1) Information on the function
of the ICD; 2) Normal
progression of physical and
em otional recovery experiences;
3) Safety and m aintenance of
the ICD; 4) A ctivities o f daily
living with the ICD; 5)
Strategies to assist w ith the
partner’s self-care.
D ecreased ICD related physical
symptoms and anxiety, and
increased SCA know ledge over
3 months.

1ST in Patients with ICDs

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Author/ Year

105

Purpose

Study Design

Kam phuis
et al
/2004

To explore how ICD
recipients perceive their
lives during the first year
after ICD im plantation

Qualitative study.
Semi- structured interview

O ’ Brien
et al
/2004

Provide an update for
clinicians on the effects
of ICD storm* on
patients and family
members.
* Storm = a series of two
or more ICD shocks
(appropriately or
inappropriately
triggered) in succession
within a 24 - hour
period.
To explore nurses'
confidence and
com petence in preparing
patients for having an
ICD im planted and for
life at home.

Case report.

Tagney
et al
/2004

Literature review and
interviews with patients
who have experienced ICD
storm

Subjects
N=Total
N = 21 ICD
recipients

M ajor Findings/Suggestions
R/T Education
Physiological deterioration,
cognitive changes, perceived
social support, dependency,
feelings regarding the
possibility o f receiving a shock,
and confrontation with
mortality.

N=6
Low number (4 or

1) Qualitative of life was
negatively affected only in
subjects who received more
than 4 shocks.
2) Pain and fear are m ajor
concerns requiring
psychological counseling.
3) There is a need for
know ledge about the purpose
of the ICD and self care
m ethods effective in reducing
the occurrence o f ICD storms.
Knowledge of the ICD and its
effects appeared poorly
understood by all nurses,
irrespective o f additional
qualifications, length of time
since qualifying or area of
work.

less) of ICD storm
shocks(n=3)
High num ber (more
than 4) of storm
shocks(n=3)

Survey.
A 28-point postal
questionnaire to explore
knowledge of the device
and its impact.

N=152 nurses.
A purposive sample
from cardiology
departments in 4
large teaching
hospitals.
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Appendix D

ICD INAPPROPRIATE SHOCK THERAPY STUDY DATA SHEET

Demographic and Clinical Characteristics
Subject Code

Patient Information
Age

Sex

M

Diagnosis / Indication
SCD
V F/V T
MUSTT/MADITII
O ther____

F__

DCM

History
Clinical History / Cardiac History before
Underlying Disease
a. Heart disease i) Other structural heart disease
b. Heart disease severity
i) Left ventricular ejection fraction
ii) NYHA Functional Classes
c. Other significant disease

Manufacturer : G uidant(G )
Implantation date(s)
mode
model

NIDCM

CHF_____

ii) Non structure heart disease

Device Information
Medtronic(M)
St. Jude (S)___
Programmer
Shock Episode (s) History

Incidence o f Shock

Appropriate sh o ck

Inappropriate shock ___

Description(s) o f Inappropriate Shock(s)
1.Energy o f shock
Joul
2.How was device programmed at the time o f shock
3.Drug(s) (Medications) at the time o f inappropriate shock
a. Anti Antiarrhythmic Therapy (AA medications)
b. Amiodarone
4.Symptoms during at the time o f inappropriate shock
5. Factors o f inappropriate shock
Termination of inappropriate shock
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APPENDIX F
Approval Letter From the Committee o f Human Research - University of California San Diego
Medical Center
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051123X

UNIVERSITY OF CALIFORNIA, SAN DIEGO
HUMAN RESEARCH PROTECTIONS PROGRAM

TO:

Dr. Ulrika Birgersdotter-G Mailcode: 8411

RE:

Project #051123X
Incidence and Clinical Predictor o f Risk Factors for Inappropriate Shock in
Patients With Implantable Cardioverter-Defibrillators (ICD)

Dear Dr. Birgersdotter-Green:
The above-referenced project was reviewed and approved on 9/1/2005 by one o f this institution's
Institutional Review Boards in accordance with the requirements o f the Code o f Federal
Regulations on the Protection o f Human Subjects (45 CFR 46 and 21 CFR 50 and 56), including
its relevant Subparts. The IRB determined that waiver o f informed consent may be granted for
this project as it meets the requirements outlined in 45 CFR 46.116(d). This
approval, based on the degree o f risk, is for 365 days from the date o f IRB review and approval
unless otherwise stated in this letter. The regulations require that continuing review be
conducted on or before the 1-year anniversary date o f the IRB approval, even though the
research activity may not begin until some time after the IRB has given approval. In addition, a
waiver of individual authorization for use o f Protected Health Information (PHI) was granted by
the Institutional Review Board as stipulated by the HIPAA Privacy Rule, 45 CFR 164 section
512(1).
The Institutional Review Board determined that the proposed research satisfies following
criteria:
1. The use or disclosure o f PHI involves no more than minimal risk.
2. Granting of waiver will not adversely affect privacy rights and welfare o f the individuals
whose records will be used.
3. The project could not practicably be conducted without a waiver.
4. The project could not practicably be conducted without use o f PHI.
5. The privacy risks are reasonable relative to the anticipated benefits o f research.
6. An adequate plan to protect identifiers from improper use and disclosure is included in
the research proposal.
7. An adequate plan to destroy the identifiers at the earliest opportunity, or justification for
retaining identifiers, is included in the research proposal.
8. The project plan includes written assurances that PHI will not be re-used or disclosed for
other purposes.
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The PHI for which use has been determined to be necessary by the IRB includes:
1. Medical records o f Implantable Cardioverter-Defibrillators (ICD) recipients who
underwent follow-up examination at 3 month intervals from January 1, 2000 to May 31,
2005 at UCSD Medical Center.
This waiver was granted using expedited review procedures.
This study was reviewed by the IRB through expedited review procedure as authorized by 45
CFR 46.110 and 21 CRF 56.110 and falls under the following research category: (5) Research
involving materials (data, documents, records, or specimens) that have been collected or will be
collected solely for nonresearch purposes (such as medical treatment or diagnosis).

/af

Mamie Gonzalez, Acting Director
Human Research Protections Program
Mailcode 0052 Phone: 858-455-5050
E-mail: hrpp@ucsd.edu

Note: All Human Subject research conducted at the VA facility and/or utilizing VA/VMRF
funds MUST BE APPROVED by the VA Research and Development Committee prior to
commencing any research. In addition, please ensure that the clinical trial agreement or other
funding is appropriately in place prior to conducting any research activities. IRB approval does
not constitute funding approval.
Approval release date: 9/15/2005
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